%PDF-1.3
3 0 obj
<>
endobj
4 0 obj
<>
stream
2 J
0.57 w
0.800 0.800 0.800 RG
0.00 w
BT /F1 10.00 Tf ET
BT /F2 12.00 Tf ET
28.35 813.54 510.24 -14.17 re S
q 0.000 g BT 31.19 802.85 Td (Economic Burden of Illness in Canada) Tj ET Q
BT /F2 10.00 Tf ET
28.35 799.37 510.24 -14.17 re S
q 0.000 g BT 31.18 789.28 Td (2010 - Canada - All Ages - All Costs) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
28.35 771.02 136.06 -14.17 re S
q 0.000 g BT 31.18 760.93 Td ( ) Tj ET Q
164.41 771.02 124.72 -14.17 re S
q 0.000 g BT 167.24 760.93 Td (Male) Tj ET Q
289.13 771.02 124.72 -14.17 re S
q 0.000 g BT 291.97 760.93 Td (Female) Tj ET Q
413.86 771.02 124.72 -14.17 re S
q 0.000 g BT 416.69 760.93 Td (Total) Tj ET Q
28.35 756.85 136.06 -14.17 re S
q 0.000 g BT 31.18 746.76 Td () Tj ET Q
164.41 756.85 124.72 -14.17 re S
q 0.000 g BT 167.24 746.76 Td (Cost) Tj ET Q
289.13 756.85 124.72 -14.17 re S
q 0.000 g BT 291.97 746.76 Td (Cost) Tj ET Q
413.86 756.85 124.72 -14.17 re S
q 0.000 g BT 416.69 746.76 Td (Cost) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
BT /F1 10.00 Tf ET
0.800 0.800 0.800 RG
0.85 w
BT /F2 10.00 Tf ET
28.35 728.50 510.24 -14.17 re S
q 0.000 g BT 31.18 718.41 Td (Certain infectious and parasitic diseases) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
BT /F1 10.00 Tf ET
28.35 714.33 136.06 -14.17 re S
q 0.000 g BT 31.18 704.24 Td (Clostridium difficile ) Tj ET Q
164.41 714.33 124.72 -14.17 re S
q 0.000 g BT 167.24 704.24 Td (35,628,215) Tj ET Q
289.13 714.33 124.72 -14.17 re S
q 0.000 g BT 291.97 704.24 Td (51,141,359) Tj ET Q
413.86 714.33 124.72 -14.17 re S
q 0.000 g BT 416.69 704.24 Td (86,769,573) Tj ET Q
28.35 700.15 136.06 -28.35 re S
q 0.000 g BT 31.18 690.07 Td (Diarrhoea and gastroenteritis) Tj ET Q
q 0.000 g BT 31.18 675.89 Td (of presumed infectious origin) Tj ET Q
164.41 700.15 124.72 -28.35 re S
q 0.000 g BT 167.24 690.07 Td (132,329,852) Tj ET Q
289.13 700.15 124.72 -28.35 re S
q 0.000 g BT 291.97 690.07 Td (165,845,978) Tj ET Q
413.86 700.15 124.72 -28.35 re S
q 0.000 g BT 416.69 690.07 Td (298,175,830) Tj ET Q
28.35 671.81 136.06 -28.35 re S
q 0.000 g BT 31.18 661.72 Td (Human immunodeficiency) Tj ET Q
q 0.000 g BT 31.18 647.55 Td (virus [HIV] disease) Tj ET Q
164.41 671.81 124.72 -28.35 re S
q 0.000 g BT 167.24 661.72 Td (155,899,894) Tj ET Q
289.13 671.81 124.72 -28.35 re S
q 0.000 g BT 291.97 661.72 Td (39,727,342) Tj ET Q
413.86 671.81 124.72 -28.35 re S
q 0.000 g BT 416.69 661.72 Td (195,627,236) Tj ET Q
28.35 643.46 136.06 -42.52 re S
q 0.000 g BT 31.18 633.37 Td (Intestinal infectious diseases) Tj ET Q
q 0.000 g BT 31.18 619.20 Td (except diarrhoea \(and C.) Tj ET Q
q 0.000 g BT 31.18 605.03 Td (difficile\)) Tj ET Q
164.41 643.46 124.72 -42.52 re S
q 0.000 g BT 167.24 633.37 Td (29,165,892) Tj ET Q
289.13 643.46 124.72 -42.52 re S
q 0.000 g BT 291.97 633.37 Td (33,898,567) Tj ET Q
413.86 643.46 124.72 -42.52 re S
q 0.000 g BT 416.69 633.37 Td (63,064,459) Tj ET Q
28.35 600.94 136.06 -28.35 re S
q 0.000 g BT 31.18 590.85 Td (Other infectious and parasitic) Tj ET Q
q 0.000 g BT 31.18 576.68 Td (diseases) Tj ET Q
164.41 600.94 124.72 -28.35 re S
q 0.000 g BT 167.24 590.85 Td (533,586,840) Tj ET Q
289.13 600.94 124.72 -28.35 re S
q 0.000 g BT 291.97 590.85 Td (501,885,866) Tj ET Q
413.86 600.94 124.72 -28.35 re S
q 0.000 g BT 416.69 590.85 Td (1,035,472,706) Tj ET Q
28.35 572.60 136.06 -14.17 re S
q 0.000 g BT 31.18 562.51 Td (Septicaemia) Tj ET Q
164.41 572.60 124.72 -14.17 re S
q 0.000 g BT 167.24 562.51 Td (276,786,497) Tj ET Q
289.13 572.60 124.72 -14.17 re S
q 0.000 g BT 291.97 562.51 Td (226,271,968) Tj ET Q
413.86 572.60 124.72 -14.17 re S
q 0.000 g BT 416.69 562.51 Td (503,058,466) Tj ET Q
28.35 558.42 136.06 -28.35 re S
q 0.000 g BT 31.18 548.34 Td (Sexually Transmitted) Tj ET Q
q 0.000 g BT 31.18 534.16 Td (Diseases) Tj ET Q
164.41 558.42 124.72 -28.35 re S
q 0.000 g BT 167.24 548.34 Td (23,157,210) Tj ET Q
289.13 558.42 124.72 -28.35 re S
q 0.000 g BT 291.97 548.34 Td (25,319,898) Tj ET Q
413.86 558.42 124.72 -28.35 re S
q 0.000 g BT 416.69 548.34 Td (48,477,108) Tj ET Q
28.35 530.08 136.06 -14.17 re S
q 0.000 g BT 31.18 519.99 Td (Tuberculosis) Tj ET Q
164.41 530.08 124.72 -14.17 re S
q 0.000 g BT 167.24 519.99 Td (18,747,438) Tj ET Q
289.13 530.08 124.72 -14.17 re S
q 0.000 g BT 291.97 519.99 Td (21,276,897) Tj ET Q
413.86 530.08 124.72 -14.17 re S
q 0.000 g BT 416.69 519.99 Td (40,024,334) Tj ET Q
BT /F2 10.00 Tf ET
28.35 515.90 136.06 -42.52 re S
q 0.000 g BT 31.18 505.82 Td (Totals for above Certain) Tj ET Q
q 0.000 g BT 31.18 491.64 Td (infectious and parasitic) Tj ET Q
q 0.000 g BT 31.18 477.47 Td (diseases) Tj ET Q
164.41 515.90 124.72 -42.52 re S
q 0.000 g BT 167.24 505.82 Td (1,205,301,838) Tj ET Q
289.13 515.90 124.72 -42.52 re S
q 0.000 g BT 291.97 505.82 Td (1,065,367,875) Tj ET Q
413.86 515.90 124.72 -42.52 re S
q 0.000 g BT 416.69 505.82 Td (2,270,669,713) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
28.35 459.21 510.24 -14.17 re S
q 0.000 g BT 31.18 449.12 Td (Neoplasms) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
BT /F1 10.00 Tf ET
28.35 445.04 136.06 -28.35 re S
q 0.000 g BT 31.18 434.95 Td (Benign neoplasm of colon,) Tj ET Q
q 0.000 g BT 31.18 420.78 Td (rectum and anus) Tj ET Q
164.41 445.04 124.72 -28.35 re S
q 0.000 g BT 167.24 434.95 Td (124,634,872) Tj ET Q
289.13 445.04 124.72 -28.35 re S
q 0.000 g BT 291.97 434.95 Td (91,396,075) Tj ET Q
413.86 445.04 124.72 -28.35 re S
q 0.000 g BT 416.69 434.95 Td (216,030,947) Tj ET Q
28.35 416.69 136.06 -14.17 re S
q 0.000 g BT 31.18 406.60 Td (Carcinoma in situ) Tj ET Q
164.41 416.69 124.72 -14.17 re S
q 0.000 g BT 167.24 406.60 Td (36,624,923) Tj ET Q
289.13 416.69 124.72 -14.17 re S
q 0.000 g BT 291.97 406.60 Td (94,178,073) Tj ET Q
413.86 416.69 124.72 -14.17 re S
q 0.000 g BT 416.69 406.60 Td (130,802,996) Tj ET Q
28.35 402.52 136.06 -14.17 re S
q 0.000 g BT 31.18 392.43 Td (Hodgkin lymphoma) Tj ET Q
164.41 402.52 124.72 -14.17 re S
q 0.000 g BT 167.24 392.43 Td (15,224,023) Tj ET Q
289.13 402.52 124.72 -14.17 re S
q 0.000 g BT 291.97 392.43 Td (9,532,317) Tj ET Q
413.86 402.52 124.72 -14.17 re S
q 0.000 g BT 416.69 392.43 Td (24,756,340) Tj ET Q
28.35 388.34 136.06 -14.17 re S
q 0.000 g BT 31.18 378.26 Td (Leiomyoma of uterus) Tj ET Q
164.41 388.34 124.72 -14.17 re S
q 0.000 g BT 167.24 378.26 Td (37,126) Tj ET Q
289.13 388.34 124.72 -14.17 re S
q 0.000 g BT 291.97 378.26 Td (117,918,444) Tj ET Q
413.86 388.34 124.72 -14.17 re S
q 0.000 g BT 416.69 378.26 Td (117,955,570) Tj ET Q
28.35 374.17 136.06 -14.17 re S
q 0.000 g BT 31.18 364.08 Td (Leukaemia) Tj ET Q
164.41 374.17 124.72 -14.17 re S
q 0.000 g BT 167.24 364.08 Td (111,982,642) Tj ET Q
289.13 374.17 124.72 -14.17 re S
q 0.000 g BT 291.97 364.08 Td (184,754,908) Tj ET Q
413.86 374.17 124.72 -14.17 re S
q 0.000 g BT 416.69 364.08 Td (296,737,550) Tj ET Q
28.35 360.00 136.06 -28.35 re S
q 0.000 g BT 31.18 349.91 Td (Malignant neoplasm of) Tj ET Q
q 0.000 g BT 31.18 335.74 Td (bladder) Tj ET Q
164.41 360.00 124.72 -28.35 re S
q 0.000 g BT 167.24 349.91 Td (112,328,981) Tj ET Q
289.13 360.00 124.72 -28.35 re S
q 0.000 g BT 291.97 349.91 Td (37,105,034) Tj ET Q
413.86 360.00 124.72 -28.35 re S
q 0.000 g BT 416.69 349.91 Td (149,434,015) Tj ET Q
28.35 331.65 136.06 -14.17 re S
q 0.000 g BT 31.18 321.56 Td (Malignant neoplasm of brain) Tj ET Q
164.41 331.65 124.72 -14.17 re S
q 0.000 g BT 167.24 321.56 Td (75,375,633) Tj ET Q
289.13 331.65 124.72 -14.17 re S
q 0.000 g BT 291.97 321.56 Td (56,542,733) Tj ET Q
413.86 331.65 124.72 -14.17 re S
q 0.000 g BT 416.69 321.56 Td (131,918,365) Tj ET Q
28.35 317.48 136.06 -28.35 re S
q 0.000 g BT 31.18 307.39 Td (Malignant neoplasm of) Tj ET Q
q 0.000 g BT 31.18 293.22 Td (breast) Tj ET Q
164.41 317.48 124.72 -28.35 re S
q 0.000 g BT 167.24 307.39 Td (2,356,127) Tj ET Q
289.13 317.48 124.72 -28.35 re S
q 0.000 g BT 291.97 307.39 Td (269,436,139) Tj ET Q
413.86 317.48 124.72 -28.35 re S
q 0.000 g BT 416.69 307.39 Td (271,792,266) Tj ET Q
28.35 289.13 136.06 -28.35 re S
q 0.000 g BT 31.18 279.04 Td (Malignant neoplasm of colon,) Tj ET Q
q 0.000 g BT 31.18 264.87 Td (rectum and anus) Tj ET Q
164.41 289.13 124.72 -28.35 re S
q 0.000 g BT 167.24 279.04 Td (288,820,699) Tj ET Q
289.13 289.13 124.72 -28.35 re S
q 0.000 g BT 291.97 279.04 Td (221,587,685) Tj ET Q
413.86 289.13 124.72 -28.35 re S
q 0.000 g BT 416.69 279.04 Td (510,408,384) Tj ET Q
28.35 260.78 136.06 -28.35 re S
q 0.000 g BT 31.18 250.70 Td (Malignant neoplasm of) Tj ET Q
q 0.000 g BT 31.18 236.52 Td (esophagus) Tj ET Q
164.41 260.78 124.72 -28.35 re S
q 0.000 g BT 167.24 250.70 Td (49,888,946) Tj ET Q
289.13 260.78 124.72 -28.35 re S
q 0.000 g BT 291.97 250.70 Td (12,717,156) Tj ET Q
413.86 260.78 124.72 -28.35 re S
q 0.000 g BT 416.69 250.70 Td (62,606,102) Tj ET Q
28.35 232.44 136.06 -28.35 re S
q 0.000 g BT 31.18 222.35 Td (Malignant neoplasm of) Tj ET Q
q 0.000 g BT 31.18 208.18 Td (kidney) Tj ET Q
164.41 232.44 124.72 -28.35 re S
q 0.000 g BT 167.24 222.35 Td (60,877,428) Tj ET Q
289.13 232.44 124.72 -28.35 re S
q 0.000 g BT 291.97 222.35 Td (33,282,414) Tj ET Q
413.86 232.44 124.72 -28.35 re S
q 0.000 g BT 416.69 222.35 Td (94,159,842) Tj ET Q
28.35 204.09 136.06 -14.17 re S
q 0.000 g BT 31.18 194.00 Td (Malignant neoplasm of larynx) Tj ET Q
164.41 204.09 124.72 -14.17 re S
q 0.000 g BT 167.24 194.00 Td (30,504,092) Tj ET Q
289.13 204.09 124.72 -14.17 re S
q 0.000 g BT 291.97 194.00 Td (5,662,724) Tj ET Q
413.86 204.09 124.72 -14.17 re S
q 0.000 g BT 416.69 194.00 Td (36,166,816) Tj ET Q
28.35 189.92 136.06 -14.17 re S
q 0.000 g BT 31.18 179.83 Td (Malignant neoplasm of liver) Tj ET Q
164.41 189.92 124.72 -14.17 re S
q 0.000 g BT 167.24 179.83 Td (27,915,012) Tj ET Q
289.13 189.92 124.72 -14.17 re S
q 0.000 g BT 291.97 179.83 Td (7,955,878) Tj ET Q
413.86 189.92 124.72 -14.17 re S
q 0.000 g BT 416.69 179.83 Td (35,870,890) Tj ET Q
28.35 175.74 136.06 -14.17 re S
q 0.000 g BT 31.18 165.66 Td (Malignant neoplasm of ovary) Tj ET Q
164.41 175.74 124.72 -14.17 re S
q 0.000 g BT 167.24 165.66 Td (48,430) Tj ET Q
289.13 175.74 124.72 -14.17 re S
q 0.000 g BT 291.97 165.66 Td (66,093,117) Tj ET Q
413.86 175.74 124.72 -14.17 re S
q 0.000 g BT 416.69 165.66 Td (66,141,547) Tj ET Q
28.35 161.57 136.06 -28.35 re S
q 0.000 g BT 31.18 151.48 Td (Malignant neoplasm of) Tj ET Q
q 0.000 g BT 31.18 137.31 Td (pancreas) Tj ET Q
164.41 161.57 124.72 -28.35 re S
q 0.000 g BT 167.24 151.48 Td (47,313,738) Tj ET Q
289.13 161.57 124.72 -28.35 re S
q 0.000 g BT 291.97 151.48 Td (41,080,026) Tj ET Q
413.86 161.57 124.72 -28.35 re S
q 0.000 g BT 416.69 151.48 Td (88,393,764) Tj ET Q
28.35 133.23 136.06 -28.35 re S
q 0.000 g BT 31.18 123.14 Td (Malignant neoplasm of) Tj ET Q
q 0.000 g BT 31.18 108.97 Td (prostate) Tj ET Q
164.41 133.23 124.72 -28.35 re S
q 0.000 g BT 167.24 123.14 Td (301,471,730) Tj ET Q
289.13 133.23 124.72 -28.35 re S
q 0.000 g BT 291.97 123.14 Td (182,104) Tj ET Q
413.86 133.23 124.72 -28.35 re S
q 0.000 g BT 416.69 123.14 Td (301,653,834) Tj ET Q
28.35 104.88 136.06 -28.35 re S
q 0.000 g BT 31.18 94.79 Td (Malignant neoplasm of) Tj ET Q
q 0.000 g BT 31.18 80.62 Td (stomach) Tj ET Q
164.41 104.88 124.72 -28.35 re S
q 0.000 g BT 167.24 94.79 Td (57,744,750) Tj ET Q
289.13 104.88 124.72 -28.35 re S
q 0.000 g BT 291.97 94.79 Td (28,467,111) Tj ET Q
413.86 104.88 124.72 -28.35 re S
q 0.000 g BT 416.69 94.79 Td (86,211,860) Tj ET Q
28.35 76.53 136.06 -14.17 re S
q 0.000 g BT 31.18 66.45 Td (Malignant neoplasm of testis) Tj ET Q
164.41 76.53 124.72 -14.17 re S
q 0.000 g BT 167.24 66.45 Td (15,537,835) Tj ET Q
289.13 76.53 124.72 -14.17 re S
q 0.000 g BT 291.97 66.45 Td (29,012) Tj ET Q
413.86 76.53 124.72 -14.17 re S
q 0.000 g BT 416.69 66.45 Td (15,566,847) Tj ET Q
endstream
endobj
5 0 obj
<>
endobj
6 0 obj
<>
stream
2 J
0.85 w
BT /F1 10.00 Tf ET
0.800 0.800 0.800 RG
28.35 813.54 136.06 -28.35 re S
q 0.000 g BT 31.18 803.46 Td (Malignant neoplasm of) Tj ET Q
q 0.000 g BT 31.18 789.28 Td (thyroid) Tj ET Q
164.41 813.54 124.72 -28.35 re S
q 0.000 g BT 167.24 803.46 Td (28,289,528) Tj ET Q
289.13 813.54 124.72 -28.35 re S
q 0.000 g BT 291.97 803.46 Td (51,066,436) Tj ET Q
413.86 813.54 124.72 -28.35 re S
q 0.000 g BT 416.69 803.46 Td (79,355,964) Tj ET Q
28.35 785.20 136.06 -28.35 re S
q 0.000 g BT 31.18 775.11 Td (Malignant neoplasm of) Tj ET Q
q 0.000 g BT 31.18 760.94 Td (uterus - Cervix uteri) Tj ET Q
164.41 785.20 124.72 -28.35 re S
q 0.000 g BT 167.24 775.11 Td (38,842) Tj ET Q
289.13 785.20 124.72 -28.35 re S
q 0.000 g BT 291.97 775.11 Td (23,749,420) Tj ET Q
413.86 785.20 124.72 -28.35 re S
q 0.000 g BT 416.69 775.11 Td (23,788,262) Tj ET Q
28.35 756.85 136.06 -28.35 re S
q 0.000 g BT 31.18 746.76 Td (Malignant neoplasm of) Tj ET Q
q 0.000 g BT 31.18 732.59 Td (uterus - Other) Tj ET Q
164.41 756.85 124.72 -28.35 re S
q 0.000 g BT 167.24 746.76 Td (23,255) Tj ET Q
289.13 756.85 124.72 -28.35 re S
q 0.000 g BT 291.97 746.76 Td (61,183,618) Tj ET Q
413.86 756.85 124.72 -28.35 re S
q 0.000 g BT 416.69 746.76 Td (61,206,873) Tj ET Q
28.35 728.50 136.06 -28.35 re S
q 0.000 g BT 31.18 718.42 Td (Malignant neoplasms of lip,) Tj ET Q
q 0.000 g BT 31.18 704.24 Td (oral cavity and pharynx) Tj ET Q
164.41 728.50 124.72 -28.35 re S
q 0.000 g BT 167.24 718.42 Td (64,576,181) Tj ET Q
289.13 728.50 124.72 -28.35 re S
q 0.000 g BT 291.97 718.42 Td (29,127,288) Tj ET Q
413.86 728.50 124.72 -28.35 re S
q 0.000 g BT 416.69 718.42 Td (93,703,469) Tj ET Q
28.35 700.16 136.06 -28.35 re S
q 0.000 g BT 31.18 690.07 Td (Malignant neoplasms of skin) Tj ET Q
q 0.000 g BT 31.18 675.90 Td (- Melanoma) Tj ET Q
164.41 700.16 124.72 -28.35 re S
q 0.000 g BT 167.24 690.07 Td (25,144,255) Tj ET Q
289.13 700.16 124.72 -28.35 re S
q 0.000 g BT 291.97 690.07 Td (15,715,072) Tj ET Q
413.86 700.16 124.72 -28.35 re S
q 0.000 g BT 416.69 690.07 Td (40,859,327) Tj ET Q
28.35 671.81 136.06 -28.35 re S
q 0.000 g BT 31.18 661.72 Td (Malignant neoplasms of skin) Tj ET Q
q 0.000 g BT 31.18 647.55 Td (- Other) Tj ET Q
164.41 671.81 124.72 -28.35 re S
q 0.000 g BT 167.24 661.72 Td (65,896,221) Tj ET Q
289.13 671.81 124.72 -28.35 re S
q 0.000 g BT 291.97 661.72 Td (48,987,556) Tj ET Q
413.86 671.81 124.72 -28.35 re S
q 0.000 g BT 416.69 661.72 Td (114,883,776) Tj ET Q
28.35 643.46 136.06 -28.35 re S
q 0.000 g BT 31.18 633.38 Td (Malignant neoplasms of) Tj ET Q
q 0.000 g BT 31.18 619.20 Td (trachea, bronchus and lung) Tj ET Q
164.41 643.46 124.72 -28.35 re S
q 0.000 g BT 167.24 633.38 Td (241,458,268) Tj ET Q
289.13 643.46 124.72 -28.35 re S
q 0.000 g BT 291.97 633.38 Td (213,763,364) Tj ET Q
413.86 643.46 124.72 -28.35 re S
q 0.000 g BT 416.69 633.38 Td (455,221,631) Tj ET Q
28.35 615.12 136.06 -14.17 re S
q 0.000 g BT 31.18 605.03 Td (Multiple myeloma) Tj ET Q
164.41 615.12 124.72 -14.17 re S
q 0.000 g BT 167.24 605.03 Td (56,190,367) Tj ET Q
289.13 615.12 124.72 -14.17 re S
q 0.000 g BT 291.97 605.03 Td (48,589,177) Tj ET Q
413.86 615.12 124.72 -14.17 re S
q 0.000 g BT 416.69 605.03 Td (104,779,545) Tj ET Q
28.35 600.95 136.06 -14.17 re S
q 0.000 g BT 31.18 590.86 Td (Non-Hodgkin lymphoma) Tj ET Q
164.41 600.95 124.72 -14.17 re S
q 0.000 g BT 167.24 590.86 Td (90,030,822) Tj ET Q
289.13 600.95 124.72 -14.17 re S
q 0.000 g BT 291.97 590.86 Td (66,519,315) Tj ET Q
413.86 600.95 124.72 -14.17 re S
q 0.000 g BT 416.69 590.86 Td (156,550,137) Tj ET Q
28.35 586.77 136.06 -42.52 re S
q 0.000 g BT 31.18 576.69 Td (Other benign neoplasms and) Tj ET Q
q 0.000 g BT 31.18 562.51 Td (neoplasms of uncertain or) Tj ET Q
q 0.000 g BT 31.18 548.34 Td (unknown behaviour) Tj ET Q
164.41 586.77 124.72 -42.52 re S
q 0.000 g BT 167.24 576.69 Td (274,996,233) Tj ET Q
289.13 586.77 124.72 -42.52 re S
q 0.000 g BT 291.97 576.69 Td (557,355,556) Tj ET Q
413.86 586.77 124.72 -42.52 re S
q 0.000 g BT 416.69 576.69 Td (832,351,789) Tj ET Q
28.35 544.25 136.06 -14.17 re S
q 0.000 g BT 31.18 534.17 Td (Other malignant neoplasms) Tj ET Q
164.41 544.25 124.72 -14.17 re S
q 0.000 g BT 167.24 534.17 Td (388,728,949) Tj ET Q
289.13 544.25 124.72 -14.17 re S
q 0.000 g BT 291.97 534.17 Td (605,775,585) Tj ET Q
413.86 544.25 124.72 -14.17 re S
q 0.000 g BT 416.69 534.17 Td (994,504,534) Tj ET Q
BT /F2 10.00 Tf ET
28.35 530.08 136.06 -28.35 re S
q 0.000 g BT 31.18 519.99 Td (Totals for above) Tj ET Q
q 0.000 g BT 31.18 505.82 Td (Neoplasms) Tj ET Q
164.41 530.08 124.72 -28.35 re S
q 0.000 g BT 167.24 519.99 Td (2,594,059,907) Tj ET Q
289.13 530.08 124.72 -28.35 re S
q 0.000 g BT 291.97 519.99 Td (2,999,753,333) Tj ET Q
413.86 530.08 124.72 -28.35 re S
q 0.000 g BT 416.69 519.99 Td (5,593,813,240) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
28.35 487.56 510.24 -14.17 re S
q 0.000 g BT 31.18 477.47 Td (Diseases of the blood & bloodforming organs & certain disorders involving the immune mechanism) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
BT /F1 10.00 Tf ET
28.35 473.39 136.06 -28.35 re S
q 0.000 g BT 31.18 463.30 Td (Anaemias - Iron-deficiency) Tj ET Q
q 0.000 g BT 31.18 449.13 Td (anaemia) Tj ET Q
164.41 473.39 124.72 -28.35 re S
q 0.000 g BT 167.24 463.30 Td (66,932,892) Tj ET Q
289.13 473.39 124.72 -28.35 re S
q 0.000 g BT 291.97 463.30 Td (136,636,749) Tj ET Q
413.86 473.39 124.72 -28.35 re S
q 0.000 g BT 416.69 463.30 Td (203,569,642) Tj ET Q
28.35 445.04 136.06 -14.17 re S
q 0.000 g BT 31.18 434.95 Td (Anaemias - Other) Tj ET Q
164.41 445.04 124.72 -14.17 re S
q 0.000 g BT 167.24 434.95 Td (111,448,561) Tj ET Q
289.13 445.04 124.72 -14.17 re S
q 0.000 g BT 291.97 434.95 Td (114,369,314) Tj ET Q
413.86 445.04 124.72 -14.17 re S
q 0.000 g BT 416.69 434.95 Td (225,817,875) Tj ET Q
28.35 430.87 136.06 -56.69 re S
q 0.000 g BT 31.18 420.78 Td (Other diseases of blood &) Tj ET Q
q 0.000 g BT 31.18 406.61 Td (blood forming organs &) Tj ET Q
q 0.000 g BT 31.18 392.43 Td (certain disorders involving) Tj ET Q
q 0.000 g BT 31.18 378.26 Td (the immune mechanism) Tj ET Q
164.41 430.87 124.72 -56.69 re S
q 0.000 g BT 167.24 420.78 Td (86,892,568) Tj ET Q
289.13 430.87 124.72 -56.69 re S
q 0.000 g BT 291.97 420.78 Td (81,018,474) Tj ET Q
413.86 430.87 124.72 -56.69 re S
q 0.000 g BT 416.69 420.78 Td (167,911,042) Tj ET Q
BT /F2 10.00 Tf ET
28.35 374.17 136.06 -70.87 re S
q 0.000 g BT 31.18 364.09 Td (Totals for above Diseases) Tj ET Q
q 0.000 g BT 31.18 349.91 Td (of the blood &) Tj ET Q
q 0.000 g BT 31.18 335.74 Td (bloodforming organs &) Tj ET Q
q 0.000 g BT 31.18 321.57 Td (certain disorders involving) Tj ET Q
q 0.000 g BT 31.18 307.39 Td (the immune mechanism) Tj ET Q
164.41 374.17 124.72 -70.87 re S
q 0.000 g BT 167.24 364.09 Td (265,274,021) Tj ET Q
289.13 374.17 124.72 -70.87 re S
q 0.000 g BT 291.97 364.09 Td (332,024,538) Tj ET Q
413.86 374.17 124.72 -70.87 re S
q 0.000 g BT 416.69 364.09 Td (597,298,559) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
28.35 289.13 510.24 -14.17 re S
q 0.000 g BT 31.18 279.05 Td (Endocrine, nutritional and metabolic diseases) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
BT /F1 10.00 Tf ET
28.35 274.96 136.06 -14.17 re S
q 0.000 g BT 31.18 264.87 Td (Diabetes mellitus) Tj ET Q
164.41 274.96 124.72 -14.17 re S
q 0.000 g BT 167.24 264.87 Td (2,792,155,086) Tj ET Q
289.13 274.96 124.72 -14.17 re S
q 0.000 g BT 291.97 264.87 Td (2,266,464,472) Tj ET Q
413.86 274.96 124.72 -14.17 re S
q 0.000 g BT 416.69 264.87 Td (5,058,619,559) Tj ET Q
28.35 260.79 136.06 -28.35 re S
q 0.000 g BT 31.18 250.70 Td (Other endocrine, nutritional) Tj ET Q
q 0.000 g BT 31.18 236.53 Td (and metabolic diseases) Tj ET Q
164.41 260.79 124.72 -28.35 re S
q 0.000 g BT 167.24 250.70 Td (169,298,277) Tj ET Q
289.13 260.79 124.72 -28.35 re S
q 0.000 g BT 291.97 250.70 Td (262,977,527) Tj ET Q
413.86 260.79 124.72 -28.35 re S
q 0.000 g BT 416.69 250.70 Td (432,275,804) Tj ET Q
BT /F2 10.00 Tf ET
28.35 232.44 136.06 -42.52 re S
q 0.000 g BT 31.18 222.35 Td (Totals for above) Tj ET Q
q 0.000 g BT 31.18 208.18 Td (Endocrine, nutritional and) Tj ET Q
q 0.000 g BT 31.18 194.01 Td (metabolic diseases) Tj ET Q
164.41 232.44 124.72 -42.52 re S
q 0.000 g BT 167.24 222.35 Td (2,961,453,363) Tj ET Q
289.13 232.44 124.72 -42.52 re S
q 0.000 g BT 291.97 222.35 Td (2,529,441,999) Tj ET Q
413.86 232.44 124.72 -42.52 re S
q 0.000 g BT 416.69 222.35 Td (5,490,895,363) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
28.35 175.75 510.24 -14.17 re S
q 0.000 g BT 31.18 165.66 Td (Mental and behavioural disorders) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
BT /F1 10.00 Tf ET
28.35 161.58 136.06 -14.17 re S
q 0.000 g BT 31.18 151.49 Td (Dementia) Tj ET Q
164.41 161.58 124.72 -14.17 re S
q 0.000 g BT 167.24 151.49 Td (266,636,053) Tj ET Q
289.13 161.58 124.72 -14.17 re S
q 0.000 g BT 291.97 151.49 Td (314,712,712) Tj ET Q
413.86 161.58 124.72 -14.17 re S
q 0.000 g BT 416.69 151.49 Td (581,348,765) Tj ET Q
28.35 147.40 136.06 -28.35 re S
q 0.000 g BT 31.18 137.32 Td (Mental and behavioural) Tj ET Q
q 0.000 g BT 31.18 123.14 Td (disorders due to alcohol) Tj ET Q
164.41 147.40 124.72 -28.35 re S
q 0.000 g BT 167.24 137.32 Td (181,178,087) Tj ET Q
289.13 147.40 124.72 -28.35 re S
q 0.000 g BT 291.97 137.32 Td (78,332,233) Tj ET Q
413.86 147.40 124.72 -28.35 re S
q 0.000 g BT 416.69 137.32 Td (259,510,320) Tj ET Q
28.35 119.06 136.06 -42.52 re S
q 0.000 g BT 31.18 108.97 Td (Mental and behavioural) Tj ET Q
q 0.000 g BT 31.18 94.80 Td (disorders due to use of other) Tj ET Q
q 0.000 g BT 31.18 80.62 Td (psychoactive subst.) Tj ET Q
164.41 119.06 124.72 -42.52 re S
q 0.000 g BT 167.24 108.97 Td (324,609,088) Tj ET Q
289.13 119.06 124.72 -42.52 re S
q 0.000 g BT 291.97 108.97 Td (197,910,323) Tj ET Q
413.86 119.06 124.72 -42.52 re S
q 0.000 g BT 416.69 108.97 Td (522,519,410) Tj ET Q
28.35 76.54 136.06 -14.17 re S
q 0.000 g BT 31.18 66.45 Td (Mood [affective] disorders) Tj ET Q
164.41 76.54 124.72 -14.17 re S
q 0.000 g BT 167.24 66.45 Td (907,158,690) Tj ET Q
289.13 76.54 124.72 -14.17 re S
q 0.000 g BT 291.97 66.45 Td (1,559,901,565) Tj ET Q
413.86 76.54 124.72 -14.17 re S
q 0.000 g BT 416.69 66.45 Td (2,467,060,255) Tj ET Q
endstream
endobj
7 0 obj
<>
endobj
8 0 obj
<>
stream
2 J
0.85 w
BT /F1 10.00 Tf ET
0.800 0.800 0.800 RG
28.35 813.54 136.06 -28.35 re S
q 0.000 g BT 31.18 803.46 Td (Other mental and) Tj ET Q
q 0.000 g BT 31.18 789.28 Td (behavioural disorders) Tj ET Q
164.41 813.54 124.72 -28.35 re S
q 0.000 g BT 167.24 803.46 Td (2,491,571,492) Tj ET Q
289.13 813.54 124.72 -28.35 re S
q 0.000 g BT 291.97 803.46 Td (2,535,259,726) Tj ET Q
413.86 813.54 124.72 -28.35 re S
q 0.000 g BT 416.69 803.46 Td (5,026,831,218) Tj ET Q
28.35 785.20 136.06 -28.35 re S
q 0.000 g BT 31.18 775.11 Td (Schizophrenia, schizotypal) Tj ET Q
q 0.000 g BT 31.18 760.94 Td (and delusional disorders) Tj ET Q
164.41 785.20 124.72 -28.35 re S
q 0.000 g BT 167.24 775.11 Td (955,437,717) Tj ET Q
289.13 785.20 124.72 -28.35 re S
q 0.000 g BT 291.97 775.11 Td (628,334,080) Tj ET Q
413.86 785.20 124.72 -28.35 re S
q 0.000 g BT 416.69 775.11 Td (1,583,771,796) Tj ET Q
BT /F2 10.00 Tf ET
28.35 756.85 136.06 -28.35 re S
q 0.000 g BT 31.18 746.76 Td (Totals for above Mental) Tj ET Q
q 0.000 g BT 31.18 732.59 Td (and behavioural disorders) Tj ET Q
164.41 756.85 124.72 -28.35 re S
q 0.000 g BT 167.24 746.76 Td (5,126,591,125) Tj ET Q
289.13 756.85 124.72 -28.35 re S
q 0.000 g BT 291.97 746.76 Td (5,314,450,639) Tj ET Q
413.86 756.85 124.72 -28.35 re S
q 0.000 g BT 416.69 746.76 Td (10,441,041,764) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
28.35 714.33 510.24 -14.17 re S
q 0.000 g BT 31.18 704.24 Td (Diseases of the nervous system) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
BT /F1 10.00 Tf ET
28.35 700.16 136.06 -14.17 re S
q 0.000 g BT 31.18 690.07 Td (Alzheimer's disease) Tj ET Q
164.41 700.16 124.72 -14.17 re S
q 0.000 g BT 167.24 690.07 Td (149,082,140) Tj ET Q
289.13 700.16 124.72 -14.17 re S
q 0.000 g BT 291.97 690.07 Td (178,405,900) Tj ET Q
413.86 700.16 124.72 -14.17 re S
q 0.000 g BT 416.69 690.07 Td (327,488,040) Tj ET Q
28.35 685.98 136.06 -14.17 re S
q 0.000 g BT 31.18 675.90 Td (Bacterial meningitis) Tj ET Q
164.41 685.98 124.72 -14.17 re S
q 0.000 g BT 167.24 675.90 Td (11,301,791) Tj ET Q
289.13 685.98 124.72 -14.17 re S
q 0.000 g BT 291.97 675.90 Td (6,686,207) Tj ET Q
413.86 685.98 124.72 -14.17 re S
q 0.000 g BT 416.69 675.90 Td (17,987,998) Tj ET Q
28.35 671.81 136.06 -14.17 re S
q 0.000 g BT 31.18 661.72 Td (Epilepsy) Tj ET Q
164.41 671.81 124.72 -14.17 re S
q 0.000 g BT 167.24 661.72 Td (94,655,427) Tj ET Q
289.13 671.81 124.72 -14.17 re S
q 0.000 g BT 291.97 661.72 Td (85,003,798) Tj ET Q
413.86 671.81 124.72 -14.17 re S
q 0.000 g BT 416.69 661.72 Td (179,659,225) Tj ET Q
28.35 657.64 136.06 -42.52 re S
q 0.000 g BT 31.18 647.55 Td (Meningitis due to other) Tj ET Q
q 0.000 g BT 31.18 633.38 Td (organisms or of unspecified) Tj ET Q
q 0.000 g BT 31.18 619.20 Td (cause) Tj ET Q
164.41 657.64 124.72 -42.52 re S
q 0.000 g BT 167.24 647.55 Td (4,771,645) Tj ET Q
289.13 657.64 124.72 -42.52 re S
q 0.000 g BT 291.97 647.55 Td (4,153,613) Tj ET Q
413.86 657.64 124.72 -42.52 re S
q 0.000 g BT 416.69 647.55 Td (8,925,258) Tj ET Q
28.35 615.12 136.06 -14.17 re S
q 0.000 g BT 31.18 605.03 Td (Migraine) Tj ET Q
164.41 615.12 124.72 -14.17 re S
q 0.000 g BT 167.24 605.03 Td (20,193,498) Tj ET Q
289.13 615.12 124.72 -14.17 re S
q 0.000 g BT 291.97 605.03 Td (60,093,568) Tj ET Q
413.86 615.12 124.72 -14.17 re S
q 0.000 g BT 416.69 605.03 Td (80,287,066) Tj ET Q
28.35 600.95 136.06 -14.17 re S
q 0.000 g BT 31.18 590.86 Td (Multiple sclerosis) Tj ET Q
164.41 600.95 124.72 -14.17 re S
q 0.000 g BT 167.24 590.86 Td (73,732,772) Tj ET Q
289.13 600.95 124.72 -14.17 re S
q 0.000 g BT 291.97 590.86 Td (244,253,009) Tj ET Q
413.86 600.95 124.72 -14.17 re S
q 0.000 g BT 416.69 590.86 Td (317,985,781) Tj ET Q
28.35 586.77 136.06 -28.35 re S
q 0.000 g BT 31.18 576.69 Td (Other diseases of the) Tj ET Q
q 0.000 g BT 31.18 562.51 Td (nervous system) Tj ET Q
164.41 586.77 124.72 -28.35 re S
q 0.000 g BT 167.24 576.69 Td (719,997,190) Tj ET Q
289.13 586.77 124.72 -28.35 re S
q 0.000 g BT 291.97 576.69 Td (804,017,044) Tj ET Q
413.86 586.77 124.72 -28.35 re S
q 0.000 g BT 416.69 576.69 Td (1,524,014,235) Tj ET Q
28.35 558.43 136.06 -28.35 re S
q 0.000 g BT 31.18 548.34 Td (Parkinson disease and) Tj ET Q
q 0.000 g BT 31.18 534.17 Td (secondary parkinsonism) Tj ET Q
164.41 558.43 124.72 -28.35 re S
q 0.000 g BT 167.24 548.34 Td (115,515,446) Tj ET Q
289.13 558.43 124.72 -28.35 re S
q 0.000 g BT 291.97 548.34 Td (65,596,465) Tj ET Q
413.86 558.43 124.72 -28.35 re S
q 0.000 g BT 416.69 548.34 Td (181,111,911) Tj ET Q
28.35 530.08 136.06 -42.52 re S
q 0.000 g BT 31.18 519.99 Td (Transient cerebral ischaemic) Tj ET Q
q 0.000 g BT 31.18 505.82 Td (attacks and related) Tj ET Q
q 0.000 g BT 31.18 491.65 Td (syndromes) Tj ET Q
164.41 530.08 124.72 -42.52 re S
q 0.000 g BT 167.24 519.99 Td (50,598,472) Tj ET Q
289.13 530.08 124.72 -42.52 re S
q 0.000 g BT 291.97 519.99 Td (51,693,284) Tj ET Q
413.86 530.08 124.72 -42.52 re S
q 0.000 g BT 416.69 519.99 Td (102,291,756) Tj ET Q
BT /F2 10.00 Tf ET
28.35 487.56 136.06 -28.35 re S
q 0.000 g BT 31.18 477.47 Td (Totals for above Diseases) Tj ET Q
q 0.000 g BT 31.18 463.30 Td (of the nervous system) Tj ET Q
164.41 487.56 124.72 -28.35 re S
q 0.000 g BT 167.24 477.47 Td (1,239,848,382) Tj ET Q
289.13 487.56 124.72 -28.35 re S
q 0.000 g BT 291.97 477.47 Td (1,499,902,889) Tj ET Q
413.86 487.56 124.72 -28.35 re S
q 0.000 g BT 416.69 477.47 Td (2,739,751,270) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
28.35 445.04 510.24 -14.17 re S
q 0.000 g BT 31.18 434.95 Td (Diseases of the eye and adnexa) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
BT /F1 10.00 Tf ET
28.35 430.87 136.06 -14.17 re S
q 0.000 g BT 31.18 420.78 Td (Cataract) Tj ET Q
164.41 430.87 124.72 -14.17 re S
q 0.000 g BT 167.24 420.78 Td (388,728,906) Tj ET Q
289.13 430.87 124.72 -14.17 re S
q 0.000 g BT 291.97 420.78 Td (524,594,681) Tj ET Q
413.86 430.87 124.72 -14.17 re S
q 0.000 g BT 416.69 420.78 Td (913,323,586) Tj ET Q
28.35 416.69 136.06 -28.35 re S
q 0.000 g BT 31.18 406.61 Td (Other diseases of the eye) Tj ET Q
q 0.000 g BT 31.18 392.43 Td (and adnexa) Tj ET Q
164.41 416.69 124.72 -28.35 re S
q 0.000 g BT 167.24 406.61 Td (744,743,894) Tj ET Q
289.13 416.69 124.72 -28.35 re S
q 0.000 g BT 291.97 406.61 Td (876,544,942) Tj ET Q
413.86 416.69 124.72 -28.35 re S
q 0.000 g BT 416.69 406.61 Td (1,621,288,836) Tj ET Q
BT /F2 10.00 Tf ET
28.35 388.35 136.06 -28.35 re S
q 0.000 g BT 31.18 378.26 Td (Totals for above Diseases) Tj ET Q
q 0.000 g BT 31.18 364.09 Td (of the eye and adnexa) Tj ET Q
164.41 388.35 124.72 -28.35 re S
q 0.000 g BT 167.24 378.26 Td (1,133,472,799) Tj ET Q
289.13 388.35 124.72 -28.35 re S
q 0.000 g BT 291.97 378.26 Td (1,401,139,623) Tj ET Q
413.86 388.35 124.72 -28.35 re S
q 0.000 g BT 416.69 378.26 Td (2,534,612,422) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
28.35 345.83 510.24 -14.17 re S
q 0.000 g BT 31.18 335.74 Td (Diseases of the ear and mastoid process) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
BT /F1 10.00 Tf ET
28.35 331.65 136.06 -14.17 re S
q 0.000 g BT 31.18 321.57 Td (Hearing loss) Tj ET Q
164.41 331.65 124.72 -14.17 re S
q 0.000 g BT 167.24 321.57 Td (38,770,137) Tj ET Q
289.13 331.65 124.72 -14.17 re S
q 0.000 g BT 291.97 321.57 Td (41,730,515) Tj ET Q
413.86 331.65 124.72 -14.17 re S
q 0.000 g BT 416.69 321.57 Td (80,500,653) Tj ET Q
28.35 317.48 136.06 -28.35 re S
q 0.000 g BT 31.18 307.39 Td (Other diseases of the ear) Tj ET Q
q 0.000 g BT 31.18 293.22 Td (and mastoid process) Tj ET Q
164.41 317.48 124.72 -28.35 re S
q 0.000 g BT 167.24 307.39 Td (132,714,927) Tj ET Q
289.13 317.48 124.72 -28.35 re S
q 0.000 g BT 291.97 307.39 Td (154,671,937) Tj ET Q
413.86 317.48 124.72 -28.35 re S
q 0.000 g BT 416.69 307.39 Td (287,386,864) Tj ET Q
28.35 289.13 136.06 -14.17 re S
q 0.000 g BT 31.18 279.05 Td (Otitis media) Tj ET Q
164.41 289.13 124.72 -14.17 re S
q 0.000 g BT 167.24 279.05 Td (188,989,279) Tj ET Q
289.13 289.13 124.72 -14.17 re S
q 0.000 g BT 291.97 279.05 Td (153,940,817) Tj ET Q
413.86 289.13 124.72 -14.17 re S
q 0.000 g BT 416.69 279.05 Td (342,930,096) Tj ET Q
BT /F2 10.00 Tf ET
28.35 274.96 136.06 -42.52 re S
q 0.000 g BT 31.18 264.87 Td (Totals for above Diseases) Tj ET Q
q 0.000 g BT 31.18 250.70 Td (of the ear and mastoid) Tj ET Q
q 0.000 g BT 31.18 236.53 Td (process) Tj ET Q
164.41 274.96 124.72 -42.52 re S
q 0.000 g BT 167.24 264.87 Td (360,474,344) Tj ET Q
289.13 274.96 124.72 -42.52 re S
q 0.000 g BT 291.97 264.87 Td (350,343,269) Tj ET Q
413.86 274.96 124.72 -42.52 re S
q 0.000 g BT 416.69 264.87 Td (710,817,613) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
28.35 218.27 510.24 -14.17 re S
q 0.000 g BT 31.18 208.18 Td (Diseases of the circulatory system) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
BT /F1 10.00 Tf ET
28.35 204.09 136.06 -14.17 re S
q 0.000 g BT 31.18 194.01 Td (Acute but ill-defined stroke) Tj ET Q
164.41 204.09 124.72 -14.17 re S
q 0.000 g BT 167.24 194.01 Td (113,332,486) Tj ET Q
289.13 204.09 124.72 -14.17 re S
q 0.000 g BT 291.97 194.01 Td (95,976,688) Tj ET Q
413.86 204.09 124.72 -14.17 re S
q 0.000 g BT 416.69 194.01 Td (209,309,174) Tj ET Q
28.35 189.92 136.06 -14.17 re S
q 0.000 g BT 31.18 179.83 Td (Acute myocardial infarction) Tj ET Q
164.41 189.92 124.72 -14.17 re S
q 0.000 g BT 167.24 179.83 Td (899,934,416) Tj ET Q
289.13 189.92 124.72 -14.17 re S
q 0.000 g BT 291.97 179.83 Td (406,768,565) Tj ET Q
413.86 189.92 124.72 -14.17 re S
q 0.000 g BT 416.69 179.83 Td (1,306,702,980) Tj ET Q
28.35 175.75 136.06 -14.17 re S
q 0.000 g BT 31.18 165.66 Td (Angina pectoris) Tj ET Q
164.41 175.75 124.72 -14.17 re S
q 0.000 g BT 167.24 165.66 Td (223,068,357) Tj ET Q
289.13 175.75 124.72 -14.17 re S
q 0.000 g BT 291.97 165.66 Td (107,303,997) Tj ET Q
413.86 175.75 124.72 -14.17 re S
q 0.000 g BT 416.69 165.66 Td (330,372,353) Tj ET Q
28.35 161.58 136.06 -14.17 re S
q 0.000 g BT 31.18 151.49 Td (Atherosclerosis) Tj ET Q
164.41 161.58 124.72 -14.17 re S
q 0.000 g BT 167.24 151.49 Td (89,124,689) Tj ET Q
289.13 161.58 124.72 -14.17 re S
q 0.000 g BT 291.97 151.49 Td (87,671,393) Tj ET Q
413.86 161.58 124.72 -14.17 re S
q 0.000 g BT 416.69 151.49 Td (176,796,081) Tj ET Q
28.35 147.40 136.06 -14.17 re S
q 0.000 g BT 31.18 137.32 Td (Cerebral infarction) Tj ET Q
164.41 147.40 124.72 -14.17 re S
q 0.000 g BT 167.24 137.32 Td (193,634,106) Tj ET Q
289.13 147.40 124.72 -14.17 re S
q 0.000 g BT 291.97 137.32 Td (170,185,328) Tj ET Q
413.86 147.40 124.72 -14.17 re S
q 0.000 g BT 416.69 137.32 Td (363,819,434) Tj ET Q
28.35 133.23 136.06 -28.35 re S
q 0.000 g BT 31.18 123.14 Td (Conduction disorders and) Tj ET Q
q 0.000 g BT 31.18 108.97 Td (cardiac arrhythmias) Tj ET Q
164.41 133.23 124.72 -28.35 re S
q 0.000 g BT 167.24 123.14 Td (596,569,191) Tj ET Q
289.13 133.23 124.72 -28.35 re S
q 0.000 g BT 291.97 123.14 Td (447,624,108) Tj ET Q
413.86 133.23 124.72 -28.35 re S
q 0.000 g BT 416.69 123.14 Td (1,044,193,299) Tj ET Q
28.35 104.88 136.06 -14.17 re S
q 0.000 g BT 31.18 94.80 Td (Essential hypertension) Tj ET Q
164.41 104.88 124.72 -14.17 re S
q 0.000 g BT 167.24 94.80 Td (262,249,021) Tj ET Q
289.13 104.88 124.72 -14.17 re S
q 0.000 g BT 291.97 94.80 Td (301,723,215) Tj ET Q
413.86 104.88 124.72 -14.17 re S
q 0.000 g BT 416.69 94.80 Td (563,972,236) Tj ET Q
28.35 90.71 136.06 -14.17 re S
q 0.000 g BT 31.18 80.62 Td (Heart failure) Tj ET Q
164.41 90.71 124.72 -14.17 re S
q 0.000 g BT 167.24 80.62 Td (332,260,543) Tj ET Q
289.13 90.71 124.72 -14.17 re S
q 0.000 g BT 291.97 80.62 Td (321,187,459) Tj ET Q
413.86 90.71 124.72 -14.17 re S
q 0.000 g BT 416.69 80.62 Td (653,448,002) Tj ET Q
28.35 76.54 136.06 -14.17 re S
q 0.000 g BT 31.18 66.45 Td (Intracerebral haemorrhage) Tj ET Q
164.41 76.54 124.72 -14.17 re S
q 0.000 g BT 167.24 66.45 Td (142,920,185) Tj ET Q
289.13 76.54 124.72 -14.17 re S
q 0.000 g BT 291.97 66.45 Td (114,517,906) Tj ET Q
413.86 76.54 124.72 -14.17 re S
q 0.000 g BT 416.69 66.45 Td (257,438,091) Tj ET Q
endstream
endobj
9 0 obj
<>
endobj
10 0 obj
<>
stream
2 J
0.85 w
BT /F1 10.00 Tf ET
0.800 0.800 0.800 RG
28.35 813.54 136.06 -28.35 re S
q 0.000 g BT 31.18 803.46 Td (Other cerebrovascular) Tj ET Q
q 0.000 g BT 31.18 789.28 Td (diseases) Tj ET Q
164.41 813.54 124.72 -28.35 re S
q 0.000 g BT 167.24 803.46 Td (78,828,759) Tj ET Q
289.13 813.54 124.72 -28.35 re S
q 0.000 g BT 291.97 803.46 Td (63,066,636) Tj ET Q
413.86 813.54 124.72 -28.35 re S
q 0.000 g BT 416.69 803.46 Td (141,895,395) Tj ET Q
28.35 785.20 136.06 -28.35 re S
q 0.000 g BT 31.18 775.11 Td (Other diseases of the) Tj ET Q
q 0.000 g BT 31.18 760.94 Td (circulatory system) Tj ET Q
164.41 785.20 124.72 -28.35 re S
q 0.000 g BT 167.24 775.11 Td (759,928,213) Tj ET Q
289.13 785.20 124.72 -28.35 re S
q 0.000 g BT 291.97 775.11 Td (501,548,933) Tj ET Q
413.86 785.20 124.72 -28.35 re S
q 0.000 g BT 416.69 775.11 Td (1,261,477,147) Tj ET Q
28.35 756.85 136.06 -14.17 re S
q 0.000 g BT 31.18 746.76 Td (Other hypertensive diseases) Tj ET Q
164.41 756.85 124.72 -14.17 re S
q 0.000 g BT 167.24 746.76 Td (139,714,491) Tj ET Q
289.13 756.85 124.72 -14.17 re S
q 0.000 g BT 291.97 746.76 Td (95,980,787) Tj ET Q
413.86 756.85 124.72 -14.17 re S
q 0.000 g BT 416.69 746.76 Td (235,695,278) Tj ET Q
28.35 742.68 136.06 -28.35 re S
q 0.000 g BT 31.18 732.59 Td (Other ischaemic heart) Tj ET Q
q 0.000 g BT 31.18 718.42 Td (diseases) Tj ET Q
164.41 742.68 124.72 -28.35 re S
q 0.000 g BT 167.24 732.59 Td (897,179,220) Tj ET Q
289.13 742.68 124.72 -28.35 re S
q 0.000 g BT 291.97 732.59 Td (306,328,457) Tj ET Q
413.86 742.68 124.72 -28.35 re S
q 0.000 g BT 416.69 732.59 Td (1,203,507,677) Tj ET Q
28.35 714.33 136.06 -42.52 re S
q 0.000 g BT 31.18 704.24 Td (Pulmonary heart disease &) Tj ET Q
q 0.000 g BT 31.18 690.07 Td (diseases of pulmonary) Tj ET Q
q 0.000 g BT 31.18 675.90 Td (circulation) Tj ET Q
164.41 714.33 124.72 -42.52 re S
q 0.000 g BT 167.24 704.24 Td (84,794,969) Tj ET Q
289.13 714.33 124.72 -42.52 re S
q 0.000 g BT 291.97 704.24 Td (101,448,171) Tj ET Q
413.86 714.33 124.72 -42.52 re S
q 0.000 g BT 416.69 704.24 Td (186,243,140) Tj ET Q
28.35 671.81 136.06 -14.17 re S
q 0.000 g BT 31.18 661.72 Td (Subarachnoid haemorrhage) Tj ET Q
164.41 671.81 124.72 -14.17 re S
q 0.000 g BT 167.24 661.72 Td (45,991,146) Tj ET Q
289.13 671.81 124.72 -14.17 re S
q 0.000 g BT 291.97 661.72 Td (68,824,357) Tj ET Q
413.86 671.81 124.72 -14.17 re S
q 0.000 g BT 416.69 661.72 Td (114,815,502) Tj ET Q
28.35 657.64 136.06 -28.35 re S
q 0.000 g BT 31.18 647.55 Td (Varicose veins of lower) Tj ET Q
q 0.000 g BT 31.18 633.38 Td (extremities) Tj ET Q
164.41 657.64 124.72 -28.35 re S
q 0.000 g BT 167.24 647.55 Td (2,841,437,811) Tj ET Q
289.13 657.64 124.72 -28.35 re S
q 0.000 g BT 291.97 647.55 Td (2,234,727,773) Tj ET Q
413.86 657.64 124.72 -28.35 re S
q 0.000 g BT 416.69 647.55 Td (5,076,165,584) Tj ET Q
BT /F2 10.00 Tf ET
28.35 629.29 136.06 -28.35 re S
q 0.000 g BT 31.18 619.20 Td (Totals for above Diseases) Tj ET Q
q 0.000 g BT 31.18 605.03 Td (of the circulatory system) Tj ET Q
164.41 629.29 124.72 -28.35 re S
q 0.000 g BT 167.24 619.20 Td (7,700,967,602) Tj ET Q
289.13 629.29 124.72 -28.35 re S
q 0.000 g BT 291.97 619.20 Td (5,424,883,772) Tj ET Q
413.86 629.29 124.72 -28.35 re S
q 0.000 g BT 416.69 619.20 Td (13,125,851,374) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
28.35 586.77 510.24 -14.17 re S
q 0.000 g BT 31.18 576.69 Td (Diseases of the respiratory system) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
BT /F1 10.00 Tf ET
28.35 572.60 136.06 -14.17 re S
q 0.000 g BT 31.18 562.51 Td (Asthma) Tj ET Q
164.41 572.60 124.72 -14.17 re S
q 0.000 g BT 167.24 562.51 Td (614,551,041) Tj ET Q
289.13 572.60 124.72 -14.17 re S
q 0.000 g BT 291.97 562.51 Td (630,876,731) Tj ET Q
413.86 572.60 124.72 -14.17 re S
q 0.000 g BT 416.69 562.51 Td (1,245,427,771) Tj ET Q
28.35 558.43 136.06 -14.17 re S
q 0.000 g BT 31.18 548.34 Td (Bronchiectasis) Tj ET Q
164.41 558.43 124.72 -14.17 re S
q 0.000 g BT 167.24 548.34 Td (95,454,977) Tj ET Q
289.13 558.43 124.72 -14.17 re S
q 0.000 g BT 291.97 548.34 Td (108,613,325) Tj ET Q
413.86 558.43 124.72 -14.17 re S
q 0.000 g BT 416.69 548.34 Td (204,068,302) Tj ET Q
28.35 544.25 136.06 -28.35 re S
q 0.000 g BT 31.18 534.17 Td (Chronic diseases of tonsils) Tj ET Q
q 0.000 g BT 31.18 519.99 Td (and adenoids) Tj ET Q
164.41 544.25 124.72 -28.35 re S
q 0.000 g BT 167.24 534.17 Td (101,183,161) Tj ET Q
289.13 544.25 124.72 -28.35 re S
q 0.000 g BT 291.97 534.17 Td (121,902,358) Tj ET Q
413.86 544.25 124.72 -28.35 re S
q 0.000 g BT 416.69 534.17 Td (223,085,519) Tj ET Q
28.35 515.91 136.06 -28.35 re S
q 0.000 g BT 31.18 505.82 Td (Chronic obstructive) Tj ET Q
q 0.000 g BT 31.18 491.65 Td (pulmonary disease) Tj ET Q
164.41 515.91 124.72 -28.35 re S
q 0.000 g BT 167.24 505.82 Td (385,037,988) Tj ET Q
289.13 515.91 124.72 -28.35 re S
q 0.000 g BT 291.97 505.82 Td (385,825,649) Tj ET Q
413.86 515.91 124.72 -28.35 re S
q 0.000 g BT 416.69 505.82 Td (770,863,637) Tj ET Q
28.35 487.56 136.06 -14.17 re S
q 0.000 g BT 31.18 477.47 Td (Influenza) Tj ET Q
164.41 487.56 124.72 -14.17 re S
q 0.000 g BT 167.24 477.47 Td (23,957,885) Tj ET Q
289.13 487.56 124.72 -14.17 re S
q 0.000 g BT 291.97 477.47 Td (26,464,654) Tj ET Q
413.86 487.56 124.72 -14.17 re S
q 0.000 g BT 416.69 477.47 Td (50,422,539) Tj ET Q
28.35 473.39 136.06 -28.35 re S
q 0.000 g BT 31.18 463.30 Td (Other acute lower respiratory) Tj ET Q
q 0.000 g BT 31.18 449.13 Td (infections) Tj ET Q
164.41 473.39 124.72 -28.35 re S
q 0.000 g BT 167.24 463.30 Td (161,562,200) Tj ET Q
289.13 473.39 124.72 -28.35 re S
q 0.000 g BT 291.97 463.30 Td (180,860,599) Tj ET Q
413.86 473.39 124.72 -28.35 re S
q 0.000 g BT 416.69 463.30 Td (342,422,798) Tj ET Q
28.35 445.04 136.06 -28.35 re S
q 0.000 g BT 31.18 434.95 Td (Other acute upper) Tj ET Q
q 0.000 g BT 31.18 420.78 Td (respiratory infections) Tj ET Q
164.41 445.04 124.72 -28.35 re S
q 0.000 g BT 167.24 434.95 Td (289,631,058) Tj ET Q
289.13 445.04 124.72 -28.35 re S
q 0.000 g BT 291.97 434.95 Td (381,252,739) Tj ET Q
413.86 445.04 124.72 -28.35 re S
q 0.000 g BT 416.69 434.95 Td (670,883,797) Tj ET Q
28.35 416.69 136.06 -28.35 re S
q 0.000 g BT 31.18 406.61 Td (Other diseases of the) Tj ET Q
q 0.000 g BT 31.18 392.43 Td (respiratory system) Tj ET Q
164.41 416.69 124.72 -28.35 re S
q 0.000 g BT 167.24 406.61 Td (501,726,930) Tj ET Q
289.13 416.69 124.72 -28.35 re S
q 0.000 g BT 291.97 406.61 Td (372,178,120) Tj ET Q
413.86 416.69 124.72 -28.35 re S
q 0.000 g BT 416.69 406.61 Td (873,905,050) Tj ET Q
28.35 388.35 136.06 -28.35 re S
q 0.000 g BT 31.18 378.26 Td (Other diseases of upper) Tj ET Q
q 0.000 g BT 31.18 364.09 Td (respiratory tract) Tj ET Q
164.41 388.35 124.72 -28.35 re S
q 0.000 g BT 167.24 378.26 Td (695,457,662) Tj ET Q
289.13 388.35 124.72 -28.35 re S
q 0.000 g BT 291.97 378.26 Td (630,128,533) Tj ET Q
413.86 388.35 124.72 -28.35 re S
q 0.000 g BT 416.69 378.26 Td (1,325,586,195) Tj ET Q
28.35 360.00 136.06 -14.17 re S
q 0.000 g BT 31.18 349.91 Td (Pneumonia) Tj ET Q
164.41 360.00 124.72 -14.17 re S
q 0.000 g BT 167.24 349.91 Td (424,239,640) Tj ET Q
289.13 360.00 124.72 -14.17 re S
q 0.000 g BT 291.97 349.91 Td (405,825,718) Tj ET Q
413.86 360.00 124.72 -14.17 re S
q 0.000 g BT 416.69 349.91 Td (830,065,359) Tj ET Q
BT /F2 10.00 Tf ET
28.35 345.83 136.06 -28.35 re S
q 0.000 g BT 31.18 335.74 Td (Totals for above Diseases) Tj ET Q
q 0.000 g BT 31.18 321.57 Td (of the respiratory system) Tj ET Q
164.41 345.83 124.72 -28.35 re S
q 0.000 g BT 167.24 335.74 Td (3,292,802,542) Tj ET Q
289.13 345.83 124.72 -28.35 re S
q 0.000 g BT 291.97 335.74 Td (3,243,928,425) Tj ET Q
413.86 345.83 124.72 -28.35 re S
q 0.000 g BT 416.69 335.74 Td (6,536,730,968) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
28.35 303.31 510.24 -14.17 re S
q 0.000 g BT 31.18 293.22 Td (Diseases of the digestive system) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
BT /F1 10.00 Tf ET
28.35 289.13 136.06 -14.17 re S
q 0.000 g BT 31.18 279.05 Td (Alcoholic liver disease) Tj ET Q
164.41 289.13 124.72 -14.17 re S
q 0.000 g BT 167.24 279.05 Td (88,808,591) Tj ET Q
289.13 289.13 124.72 -14.17 re S
q 0.000 g BT 291.97 279.05 Td (37,636,893) Tj ET Q
413.86 289.13 124.72 -14.17 re S
q 0.000 g BT 416.69 279.05 Td (126,445,485) Tj ET Q
28.35 274.96 136.06 -14.17 re S
q 0.000 g BT 31.18 264.87 Td (Cholelithiasis) Tj ET Q
164.41 274.96 124.72 -14.17 re S
q 0.000 g BT 167.24 264.87 Td (69,220,449) Tj ET Q
289.13 274.96 124.72 -14.17 re S
q 0.000 g BT 291.97 264.87 Td (88,364,298) Tj ET Q
413.86 274.96 124.72 -14.17 re S
q 0.000 g BT 416.69 264.87 Td (157,584,747) Tj ET Q
28.35 260.79 136.06 -28.35 re S
q 0.000 g BT 31.18 250.70 Td (Crohn's disease and) Tj ET Q
q 0.000 g BT 31.18 236.53 Td (ulcerative colitis) Tj ET Q
164.41 260.79 124.72 -28.35 re S
q 0.000 g BT 167.24 250.70 Td (161,572,683) Tj ET Q
289.13 260.79 124.72 -28.35 re S
q 0.000 g BT 291.97 250.70 Td (166,098,489) Tj ET Q
413.86 260.79 124.72 -28.35 re S
q 0.000 g BT 416.69 250.70 Td (327,671,172) Tj ET Q
28.35 232.44 136.06 -14.17 re S
q 0.000 g BT 31.18 222.35 Td (Diseases of anus and rectum) Tj ET Q
164.41 232.44 124.72 -14.17 re S
q 0.000 g BT 167.24 222.35 Td (204,122,532) Tj ET Q
289.13 232.44 124.72 -14.17 re S
q 0.000 g BT 291.97 222.35 Td (187,384,199) Tj ET Q
413.86 232.44 124.72 -14.17 re S
q 0.000 g BT 416.69 222.35 Td (391,506,731) Tj ET Q
28.35 218.27 136.06 -14.17 re S
q 0.000 g BT 31.18 208.18 Td (Diseases of appendix) Tj ET Q
164.41 218.27 124.72 -14.17 re S
q 0.000 g BT 167.24 208.18 Td (139,542,466) Tj ET Q
289.13 218.27 124.72 -14.17 re S
q 0.000 g BT 291.97 208.18 Td (118,195,619) Tj ET Q
413.86 218.27 124.72 -14.17 re S
q 0.000 g BT 416.69 208.18 Td (257,738,085) Tj ET Q
28.35 204.09 136.06 -14.17 re S
q 0.000 g BT 31.18 194.01 Td (Diseases of oesophagus) Tj ET Q
164.41 204.09 124.72 -14.17 re S
q 0.000 g BT 167.24 194.01 Td (132,781,643) Tj ET Q
289.13 204.09 124.72 -14.17 re S
q 0.000 g BT 291.97 194.01 Td (118,484,478) Tj ET Q
413.86 204.09 124.72 -14.17 re S
q 0.000 g BT 416.69 194.01 Td (251,266,121) Tj ET Q
28.35 189.92 136.06 -14.17 re S
q 0.000 g BT 31.18 179.83 Td (Diseases of pancreas) Tj ET Q
164.41 189.92 124.72 -14.17 re S
q 0.000 g BT 167.24 179.83 Td (857,929,875) Tj ET Q
289.13 189.92 124.72 -14.17 re S
q 0.000 g BT 291.97 179.83 Td (870,872,775) Tj ET Q
413.86 189.92 124.72 -14.17 re S
q 0.000 g BT 416.69 179.83 Td (1,728,802,650) Tj ET Q
28.35 175.75 136.06 -28.35 re S
q 0.000 g BT 31.18 165.66 Td (Diseases of the teeth and) Tj ET Q
q 0.000 g BT 31.18 151.49 Td (supporting structures) Tj ET Q
164.41 175.75 124.72 -28.35 re S
q 0.000 g BT 167.24 165.66 Td (305,385,031) Tj ET Q
289.13 175.75 124.72 -28.35 re S
q 0.000 g BT 291.97 165.66 Td (290,745,100) Tj ET Q
413.86 175.75 124.72 -28.35 re S
q 0.000 g BT 416.69 165.66 Td (596,130,130) Tj ET Q
28.35 147.40 136.06 -28.35 re S
q 0.000 g BT 31.18 137.32 Td (Diverticular disease of) Tj ET Q
q 0.000 g BT 31.18 123.14 Td (intestine) Tj ET Q
164.41 147.40 124.72 -28.35 re S
q 0.000 g BT 167.24 137.32 Td (95,611,516) Tj ET Q
289.13 147.40 124.72 -28.35 re S
q 0.000 g BT 291.97 137.32 Td (119,310,665) Tj ET Q
413.86 147.40 124.72 -28.35 re S
q 0.000 g BT 416.69 137.32 Td (214,922,180) Tj ET Q
28.35 119.06 136.06 -42.52 re S
q 0.000 g BT 31.18 108.97 Td (Dyspepsia and other) Tj ET Q
q 0.000 g BT 31.18 94.80 Td (diseases of stomach and) Tj ET Q
q 0.000 g BT 31.18 80.62 Td (duodenum) Tj ET Q
164.41 119.06 124.72 -42.52 re S
q 0.000 g BT 167.24 108.97 Td (253,638,236) Tj ET Q
289.13 119.06 124.72 -42.52 re S
q 0.000 g BT 291.97 108.97 Td (362,698,931) Tj ET Q
413.86 119.06 124.72 -42.52 re S
q 0.000 g BT 416.69 108.97 Td (616,337,167) Tj ET Q
28.35 76.54 136.06 -14.17 re S
q 0.000 g BT 31.18 66.45 Td (Fibrosis and cirrhosis of liver) Tj ET Q
164.41 76.54 124.72 -14.17 re S
q 0.000 g BT 167.24 66.45 Td (100,952,192) Tj ET Q
289.13 76.54 124.72 -14.17 re S
q 0.000 g BT 291.97 66.45 Td (88,556,320) Tj ET Q
413.86 76.54 124.72 -14.17 re S
q 0.000 g BT 416.69 66.45 Td (189,508,512) Tj ET Q
endstream
endobj
11 0 obj
<>
endobj
12 0 obj
<>
stream
2 J
0.85 w
BT /F1 10.00 Tf ET
0.800 0.800 0.800 RG
28.35 813.54 136.06 -14.17 re S
q 0.000 g BT 31.18 803.46 Td (Inguinal hernia) Tj ET Q
164.41 813.54 124.72 -14.17 re S
q 0.000 g BT 167.24 803.46 Td (252,323,221) Tj ET Q
289.13 813.54 124.72 -14.17 re S
q 0.000 g BT 291.97 803.46 Td (30,197,392) Tj ET Q
413.86 813.54 124.72 -14.17 re S
q 0.000 g BT 416.69 803.46 Td (282,520,613) Tj ET Q
28.35 799.37 136.06 -14.17 re S
q 0.000 g BT 31.18 789.28 Td (Other abdominal hernia) Tj ET Q
164.41 799.37 124.72 -14.17 re S
q 0.000 g BT 167.24 789.28 Td (153,282,451) Tj ET Q
289.13 799.37 124.72 -14.17 re S
q 0.000 g BT 291.97 789.28 Td (158,094,092) Tj ET Q
413.86 799.37 124.72 -14.17 re S
q 0.000 g BT 416.69 789.28 Td (311,376,542) Tj ET Q
28.35 785.20 136.06 -28.35 re S
q 0.000 g BT 31.18 775.11 Td (Other diseases of gall) Tj ET Q
q 0.000 g BT 31.18 760.94 Td (bladder and biliary tract) Tj ET Q
164.41 785.20 124.72 -28.35 re S
q 0.000 g BT 167.24 775.11 Td (118,757,006) Tj ET Q
289.13 785.20 124.72 -28.35 re S
q 0.000 g BT 291.97 775.11 Td (102,580,542) Tj ET Q
413.86 785.20 124.72 -28.35 re S
q 0.000 g BT 416.69 775.11 Td (221,337,548) Tj ET Q
28.35 756.85 136.06 -14.17 re S
q 0.000 g BT 31.18 746.76 Td (Other diseases of intestine) Tj ET Q
164.41 756.85 124.72 -14.17 re S
q 0.000 g BT 167.24 746.76 Td (192,916,534) Tj ET Q
289.13 756.85 124.72 -14.17 re S
q 0.000 g BT 291.97 746.76 Td (258,481,457) Tj ET Q
413.86 756.85 124.72 -14.17 re S
q 0.000 g BT 416.69 746.76 Td (451,397,991) Tj ET Q
28.35 742.68 136.06 -14.17 re S
q 0.000 g BT 31.18 732.59 Td (Other diseases of liver) Tj ET Q
164.41 742.68 124.72 -14.17 re S
q 0.000 g BT 167.24 732.59 Td (155,272,021) Tj ET Q
289.13 742.68 124.72 -14.17 re S
q 0.000 g BT 291.97 732.59 Td (368,487,114) Tj ET Q
413.86 742.68 124.72 -14.17 re S
q 0.000 g BT 416.69 732.59 Td (523,759,135) Tj ET Q
28.35 728.50 136.06 -28.35 re S
q 0.000 g BT 31.18 718.42 Td (Other diseases of oral cavity,) Tj ET Q
q 0.000 g BT 31.18 704.24 Td (salivary glands and jaws) Tj ET Q
164.41 728.50 124.72 -28.35 re S
q 0.000 g BT 167.24 718.42 Td (49,098,902) Tj ET Q
289.13 728.50 124.72 -28.35 re S
q 0.000 g BT 291.97 718.42 Td (55,602,596) Tj ET Q
413.86 728.50 124.72 -28.35 re S
q 0.000 g BT 416.69 718.42 Td (104,701,498) Tj ET Q
28.35 700.16 136.06 -28.35 re S
q 0.000 g BT 31.18 690.07 Td (Other diseases of the) Tj ET Q
q 0.000 g BT 31.18 675.90 Td (digestive system) Tj ET Q
164.41 700.16 124.72 -28.35 re S
q 0.000 g BT 167.24 690.07 Td (1,673,819) Tj ET Q
289.13 700.16 124.72 -28.35 re S
q 0.000 g BT 291.97 690.07 Td (434,691) Tj ET Q
413.86 700.16 124.72 -28.35 re S
q 0.000 g BT 416.69 690.07 Td (2,108,510) Tj ET Q
28.35 671.81 136.06 -28.35 re S
q 0.000 g BT 31.18 661.72 Td (Other noninfective) Tj ET Q
q 0.000 g BT 31.18 647.55 Td (gastroenteritis and colitis) Tj ET Q
164.41 671.81 124.72 -28.35 re S
q 0.000 g BT 167.24 661.72 Td (28,378,291) Tj ET Q
289.13 671.81 124.72 -28.35 re S
q 0.000 g BT 291.97 661.72 Td (42,262,904) Tj ET Q
413.86 671.81 124.72 -28.35 re S
q 0.000 g BT 416.69 661.72 Td (70,641,195) Tj ET Q
28.35 643.46 136.06 -28.35 re S
q 0.000 g BT 31.18 633.38 Td (Paralytic ileus and intestinal) Tj ET Q
q 0.000 g BT 31.18 619.20 Td (obstruction without hernia) Tj ET Q
164.41 643.46 124.72 -28.35 re S
q 0.000 g BT 167.24 633.38 Td (142,722,336) Tj ET Q
289.13 643.46 124.72 -28.35 re S
q 0.000 g BT 291.97 633.38 Td (170,892,816) Tj ET Q
413.86 643.46 124.72 -28.35 re S
q 0.000 g BT 416.69 633.38 Td (313,615,151) Tj ET Q
28.35 615.12 136.06 -14.17 re S
q 0.000 g BT 31.18 605.03 Td (Peptic ulcer) Tj ET Q
164.41 615.12 124.72 -14.17 re S
q 0.000 g BT 167.24 605.03 Td (97,909,812) Tj ET Q
289.13 615.12 124.72 -14.17 re S
q 0.000 g BT 291.97 605.03 Td (96,372,845) Tj ET Q
413.86 615.12 124.72 -14.17 re S
q 0.000 g BT 416.69 605.03 Td (194,282,657) Tj ET Q
BT /F2 10.00 Tf ET
28.35 600.95 136.06 -28.35 re S
q 0.000 g BT 31.18 590.86 Td (Totals for above Diseases) Tj ET Q
q 0.000 g BT 31.18 576.69 Td (of the digestive system) Tj ET Q
164.41 600.95 124.72 -28.35 re S
q 0.000 g BT 167.24 590.86 Td (3,601,899,607) Tj ET Q
289.13 600.95 124.72 -28.35 re S
q 0.000 g BT 291.97 590.86 Td (3,731,754,215) Tj ET Q
413.86 600.95 124.72 -28.35 re S
q 0.000 g BT 416.69 590.86 Td (7,333,653,821) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
28.35 558.43 510.24 -14.17 re S
q 0.000 g BT 31.18 548.34 Td (Diseases of the skin and subcutaneous tissue) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
BT /F1 10.00 Tf ET
28.35 544.25 136.06 -28.35 re S
q 0.000 g BT 31.18 534.17 Td (Dermatitis, eczema and) Tj ET Q
q 0.000 g BT 31.18 519.99 Td (papulosquamous disorders) Tj ET Q
164.41 544.25 124.72 -28.35 re S
q 0.000 g BT 167.24 534.17 Td (349,371,453) Tj ET Q
289.13 544.25 124.72 -28.35 re S
q 0.000 g BT 291.97 534.17 Td (377,794,185) Tj ET Q
413.86 544.25 124.72 -28.35 re S
q 0.000 g BT 416.69 534.17 Td (727,165,638) Tj ET Q
28.35 515.91 136.06 -28.35 re S
q 0.000 g BT 31.18 505.82 Td (Infections of the skin and) Tj ET Q
q 0.000 g BT 31.18 491.65 Td (subcutaneous tissue) Tj ET Q
164.41 515.91 124.72 -28.35 re S
q 0.000 g BT 167.24 505.82 Td (275,951,544) Tj ET Q
289.13 515.91 124.72 -28.35 re S
q 0.000 g BT 291.97 505.82 Td (239,377,654) Tj ET Q
413.86 515.91 124.72 -28.35 re S
q 0.000 g BT 416.69 505.82 Td (515,329,199) Tj ET Q
28.35 487.56 136.06 -28.35 re S
q 0.000 g BT 31.18 477.47 Td (Other diseases of the skin) Tj ET Q
q 0.000 g BT 31.18 463.30 Td (and subcutaneous tissue) Tj ET Q
164.41 487.56 124.72 -28.35 re S
q 0.000 g BT 167.24 477.47 Td (351,583,078) Tj ET Q
289.13 487.56 124.72 -28.35 re S
q 0.000 g BT 291.97 477.47 Td (477,286,771) Tj ET Q
413.86 487.56 124.72 -28.35 re S
q 0.000 g BT 416.69 477.47 Td (828,869,850) Tj ET Q
BT /F2 10.00 Tf ET
28.35 459.21 136.06 -42.52 re S
q 0.000 g BT 31.18 449.13 Td (Totals for above Diseases) Tj ET Q
q 0.000 g BT 31.18 434.95 Td (of the skin and) Tj ET Q
q 0.000 g BT 31.18 420.78 Td (subcutaneous tissue) Tj ET Q
164.41 459.21 124.72 -42.52 re S
q 0.000 g BT 167.24 449.13 Td (976,906,076) Tj ET Q
289.13 459.21 124.72 -42.52 re S
q 0.000 g BT 291.97 449.13 Td (1,094,458,611) Tj ET Q
413.86 459.21 124.72 -42.52 re S
q 0.000 g BT 416.69 449.13 Td (2,071,364,686) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
28.35 402.52 510.24 -14.17 re S
q 0.000 g BT 31.18 392.43 Td (Diseases of the musculoskeletal system and connective tissue) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
BT /F1 10.00 Tf ET
28.35 388.35 136.06 -14.17 re S
q 0.000 g BT 31.18 378.26 Td (Coxarthrosis [arthrosis of hip]) Tj ET Q
164.41 388.35 124.72 -14.17 re S
q 0.000 g BT 167.24 378.26 Td (129,845,490) Tj ET Q
289.13 388.35 124.72 -14.17 re S
q 0.000 g BT 291.97 378.26 Td (151,537,716) Tj ET Q
413.86 388.35 124.72 -14.17 re S
q 0.000 g BT 416.69 378.26 Td (281,383,206) Tj ET Q
28.35 374.17 136.06 -28.35 re S
q 0.000 g BT 31.18 364.09 Td (Deforming dorsopathies and) Tj ET Q
q 0.000 g BT 31.18 349.91 Td (spondylopathies) Tj ET Q
164.41 374.17 124.72 -28.35 re S
q 0.000 g BT 167.24 364.09 Td (264,501,890) Tj ET Q
289.13 374.17 124.72 -28.35 re S
q 0.000 g BT 291.97 364.09 Td (220,469,567) Tj ET Q
413.86 374.17 124.72 -28.35 re S
q 0.000 g BT 416.69 364.09 Td (484,971,457) Tj ET Q
28.35 345.83 136.06 -14.17 re S
q 0.000 g BT 31.18 335.74 Td (Dorsalgia) Tj ET Q
164.41 345.83 124.72 -14.17 re S
q 0.000 g BT 167.24 335.74 Td (262,457,177) Tj ET Q
289.13 345.83 124.72 -14.17 re S
q 0.000 g BT 291.97 335.74 Td (284,908,205) Tj ET Q
413.86 345.83 124.72 -14.17 re S
q 0.000 g BT 416.69 335.74 Td (547,365,382) Tj ET Q
28.35 331.65 136.06 -28.35 re S
q 0.000 g BT 31.18 321.57 Td (Gonarthrosis [arthrosis of) Tj ET Q
q 0.000 g BT 31.18 307.39 Td (knee]) Tj ET Q
164.41 331.65 124.72 -28.35 re S
q 0.000 g BT 167.24 321.57 Td (190,153,553) Tj ET Q
289.13 331.65 124.72 -28.35 re S
q 0.000 g BT 291.97 321.57 Td (274,425,388) Tj ET Q
413.86 331.65 124.72 -28.35 re S
q 0.000 g BT 416.69 321.57 Td (464,578,941) Tj ET Q
28.35 303.31 136.06 -14.17 re S
q 0.000 g BT 31.18 293.22 Td (Gout) Tj ET Q
164.41 303.31 124.72 -14.17 re S
q 0.000 g BT 167.24 293.22 Td (14,559,916) Tj ET Q
289.13 303.31 124.72 -14.17 re S
q 0.000 g BT 291.97 293.22 Td (5,817,865) Tj ET Q
413.86 303.31 124.72 -14.17 re S
q 0.000 g BT 416.69 293.22 Td (20,377,781) Tj ET Q
28.35 289.13 136.06 -28.35 re S
q 0.000 g BT 31.18 279.05 Td (Internal derangement of) Tj ET Q
q 0.000 g BT 31.18 264.87 Td (knee) Tj ET Q
164.41 289.13 124.72 -28.35 re S
q 0.000 g BT 167.24 279.05 Td (190,277,722) Tj ET Q
289.13 289.13 124.72 -28.35 re S
q 0.000 g BT 291.97 279.05 Td (124,659,559) Tj ET Q
413.86 289.13 124.72 -28.35 re S
q 0.000 g BT 416.69 279.05 Td (314,937,281) Tj ET Q
28.35 260.79 136.06 -14.17 re S
q 0.000 g BT 31.18 250.70 Td (Intervertebral disc disorders) Tj ET Q
164.41 260.79 124.72 -14.17 re S
q 0.000 g BT 167.24 250.70 Td (131,276,545) Tj ET Q
289.13 260.79 124.72 -14.17 re S
q 0.000 g BT 291.97 250.70 Td (117,237,718) Tj ET Q
413.86 260.79 124.72 -14.17 re S
q 0.000 g BT 416.69 250.70 Td (248,514,263) Tj ET Q
28.35 246.61 136.06 -14.17 re S
q 0.000 g BT 31.18 236.53 Td (Osteoporosis) Tj ET Q
164.41 246.61 124.72 -14.17 re S
q 0.000 g BT 167.24 236.53 Td (62,704,630) Tj ET Q
289.13 246.61 124.72 -14.17 re S
q 0.000 g BT 291.97 236.53 Td (459,723,249) Tj ET Q
413.86 246.61 124.72 -14.17 re S
q 0.000 g BT 416.69 236.53 Td (522,427,879) Tj ET Q
28.35 232.44 136.06 -14.17 re S
q 0.000 g BT 31.18 222.35 Td (Other arthropathies) Tj ET Q
164.41 232.44 124.72 -14.17 re S
q 0.000 g BT 167.24 222.35 Td (453,673,747) Tj ET Q
289.13 232.44 124.72 -14.17 re S
q 0.000 g BT 291.97 222.35 Td (848,706,275) Tj ET Q
413.86 232.44 124.72 -14.17 re S
q 0.000 g BT 416.69 222.35 Td (1,302,380,022) Tj ET Q
28.35 218.27 136.06 -14.17 re S
q 0.000 g BT 31.18 208.18 Td (Other arthrosis) Tj ET Q
164.41 218.27 124.72 -14.17 re S
q 0.000 g BT 167.24 208.18 Td (132,373,825) Tj ET Q
289.13 218.27 124.72 -14.17 re S
q 0.000 g BT 291.97 208.18 Td (200,701,298) Tj ET Q
413.86 218.27 124.72 -14.17 re S
q 0.000 g BT 416.69 208.18 Td (333,075,123) Tj ET Q
28.35 204.09 136.06 -42.52 re S
q 0.000 g BT 31.18 194.01 Td (Other disorders of the) Tj ET Q
q 0.000 g BT 31.18 179.83 Td (musculoskeletal system and) Tj ET Q
q 0.000 g BT 31.18 165.66 Td (connective tissue) Tj ET Q
164.41 204.09 124.72 -42.52 re S
q 0.000 g BT 167.24 194.01 Td (402,131,019) Tj ET Q
289.13 204.09 124.72 -42.52 re S
q 0.000 g BT 291.97 194.01 Td (582,620,494) Tj ET Q
413.86 204.09 124.72 -42.52 re S
q 0.000 g BT 416.69 194.01 Td (984,751,513) Tj ET Q
28.35 161.58 136.06 -14.17 re S
q 0.000 g BT 31.18 151.49 Td (Rheumatoid arthritis) Tj ET Q
164.41 161.58 124.72 -14.17 re S
q 0.000 g BT 167.24 151.49 Td (134,200,760) Tj ET Q
289.13 161.58 124.72 -14.17 re S
q 0.000 g BT 291.97 151.49 Td (287,028,889) Tj ET Q
413.86 161.58 124.72 -14.17 re S
q 0.000 g BT 416.69 151.49 Td (421,229,649) Tj ET Q
28.35 147.40 136.06 -14.17 re S
q 0.000 g BT 31.18 137.32 Td (Soft tissue disorders) Tj ET Q
164.41 147.40 124.72 -14.17 re S
q 0.000 g BT 167.24 137.32 Td (300,760,084) Tj ET Q
289.13 147.40 124.72 -14.17 re S
q 0.000 g BT 291.97 137.32 Td (317,516,953) Tj ET Q
413.86 147.40 124.72 -14.17 re S
q 0.000 g BT 416.69 137.32 Td (618,277,037) Tj ET Q
28.35 133.23 136.06 -28.35 re S
q 0.000 g BT 31.18 123.14 Td (Systemic connective tissue) Tj ET Q
q 0.000 g BT 31.18 108.97 Td (disorders) Tj ET Q
164.41 133.23 124.72 -28.35 re S
q 0.000 g BT 167.24 123.14 Td (34,314,794) Tj ET Q
289.13 133.23 124.72 -28.35 re S
q 0.000 g BT 291.97 123.14 Td (118,599,139) Tj ET Q
413.86 133.23 124.72 -28.35 re S
q 0.000 g BT 416.69 123.14 Td (152,913,933) Tj ET Q
BT /F2 10.00 Tf ET
endstream
endobj
13 0 obj
<>
endobj
14 0 obj
<>
stream
2 J
0.85 w
BT /F2 10.00 Tf ET
0.800 0.800 0.800 RG
28.35 813.54 136.06 -56.69 re S
q 0.000 g BT 31.18 803.46 Td (Totals for above Diseases) Tj ET Q
q 0.000 g BT 31.18 789.28 Td (of the musculoskeletal) Tj ET Q
q 0.000 g BT 31.18 775.11 Td (system and connective) Tj ET Q
q 0.000 g BT 31.18 760.94 Td (tissue) Tj ET Q
164.41 813.54 124.72 -56.69 re S
q 0.000 g BT 167.24 803.46 Td (2,703,231,153) Tj ET Q
289.13 813.54 124.72 -56.69 re S
q 0.000 g BT 291.97 803.46 Td (3,993,952,316) Tj ET Q
413.86 813.54 124.72 -56.69 re S
q 0.000 g BT 416.69 803.46 Td (6,697,183,469) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
28.35 742.68 510.24 -14.17 re S
q 0.000 g BT 31.18 732.59 Td (Diseases of the genitourinary system) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
BT /F1 10.00 Tf ET
28.35 728.50 136.06 -14.17 re S
q 0.000 g BT 31.18 718.42 Td (Acute renal failure) Tj ET Q
164.41 728.50 124.72 -14.17 re S
q 0.000 g BT 167.24 718.42 Td (120,406,838) Tj ET Q
289.13 728.50 124.72 -14.17 re S
q 0.000 g BT 291.97 718.42 Td (98,143,425) Tj ET Q
413.86 728.50 124.72 -14.17 re S
q 0.000 g BT 416.69 718.42 Td (218,550,263) Tj ET Q
28.35 714.33 136.06 -14.17 re S
q 0.000 g BT 31.18 704.24 Td (Chronic renal failure) Tj ET Q
164.41 714.33 124.72 -14.17 re S
q 0.000 g BT 167.24 704.24 Td (229,829,221) Tj ET Q
289.13 714.33 124.72 -14.17 re S
q 0.000 g BT 291.97 704.24 Td (165,316,871) Tj ET Q
413.86 714.33 124.72 -14.17 re S
q 0.000 g BT 416.69 704.24 Td (395,146,093) Tj ET Q
28.35 700.16 136.06 -14.17 re S
q 0.000 g BT 31.18 690.07 Td (Disorders of breast) Tj ET Q
164.41 700.16 124.72 -14.17 re S
q 0.000 g BT 167.24 690.07 Td (23,006,194) Tj ET Q
289.13 700.16 124.72 -14.17 re S
q 0.000 g BT 291.97 690.07 Td (210,041,755) Tj ET Q
413.86 700.16 124.72 -14.17 re S
q 0.000 g BT 416.69 690.07 Td (233,047,949) Tj ET Q
28.35 685.98 136.06 -28.35 re S
q 0.000 g BT 31.18 675.90 Td (Glomerular and renal) Tj ET Q
q 0.000 g BT 31.18 661.72 Td (tubulo-interstitial diseases) Tj ET Q
164.41 685.98 124.72 -28.35 re S
q 0.000 g BT 167.24 675.90 Td (103,002,881) Tj ET Q
289.13 685.98 124.72 -28.35 re S
q 0.000 g BT 291.97 675.90 Td (159,249,595) Tj ET Q
413.86 685.98 124.72 -28.35 re S
q 0.000 g BT 416.69 675.90 Td (262,252,476) Tj ET Q
28.35 657.64 136.06 -14.17 re S
q 0.000 g BT 31.18 647.55 Td (Hyperplasia of prostate) Tj ET Q
164.41 657.64 124.72 -14.17 re S
q 0.000 g BT 167.24 647.55 Td (348,454,762) Tj ET Q
289.13 657.64 124.72 -14.17 re S
q 0.000 g BT 291.97 647.55 Td (234,737) Tj ET Q
413.86 657.64 124.72 -14.17 re S
q 0.000 g BT 416.69 647.55 Td (348,689,498) Tj ET Q
28.35 643.46 136.06 -28.35 re S
q 0.000 g BT 31.18 633.38 Td (Inflammatory diseases of) Tj ET Q
q 0.000 g BT 31.18 619.20 Td (female pelvic organs) Tj ET Q
164.41 643.46 124.72 -28.35 re S
q 0.000 g BT 167.24 633.38 Td (266,369) Tj ET Q
289.13 643.46 124.72 -28.35 re S
q 0.000 g BT 291.97 633.38 Td (141,066,648) Tj ET Q
413.86 643.46 124.72 -28.35 re S
q 0.000 g BT 416.69 633.38 Td (141,333,017) Tj ET Q
28.35 615.12 136.06 -42.52 re S
q 0.000 g BT 31.18 605.03 Td (Menstrual, menopausal and) Tj ET Q
q 0.000 g BT 31.18 590.86 Td (other female genital) Tj ET Q
q 0.000 g BT 31.18 576.69 Td (conditions) Tj ET Q
164.41 615.12 124.72 -42.52 re S
q 0.000 g BT 167.24 605.03 Td (554,982) Tj ET Q
289.13 615.12 124.72 -42.52 re S
q 0.000 g BT 291.97 605.03 Td (531,743,561) Tj ET Q
413.86 615.12 124.72 -42.52 re S
q 0.000 g BT 416.69 605.03 Td (532,298,543) Tj ET Q
28.35 572.60 136.06 -28.35 re S
q 0.000 g BT 31.18 562.51 Td (Other diseases of male) Tj ET Q
q 0.000 g BT 31.18 548.34 Td (genital organs) Tj ET Q
164.41 572.60 124.72 -28.35 re S
q 0.000 g BT 167.24 562.51 Td (272,191,737) Tj ET Q
289.13 572.60 124.72 -28.35 re S
q 0.000 g BT 291.97 562.51 Td (506,005) Tj ET Q
413.86 572.60 124.72 -28.35 re S
q 0.000 g BT 416.69 562.51 Td (272,697,741) Tj ET Q
28.35 544.25 136.06 -28.35 re S
q 0.000 g BT 31.18 534.17 Td (Other diseases of the urinary) Tj ET Q
q 0.000 g BT 31.18 519.99 Td (system) Tj ET Q
164.41 544.25 124.72 -28.35 re S
q 0.000 g BT 167.24 534.17 Td (305,231,527) Tj ET Q
289.13 544.25 124.72 -28.35 re S
q 0.000 g BT 291.97 534.17 Td (682,893,719) Tj ET Q
413.86 544.25 124.72 -28.35 re S
q 0.000 g BT 416.69 534.17 Td (988,125,246) Tj ET Q
28.35 515.91 136.06 -28.35 re S
q 0.000 g BT 31.18 505.82 Td (Other disorders of the) Tj ET Q
q 0.000 g BT 31.18 491.65 Td (genitourinary system) Tj ET Q
164.41 515.91 124.72 -28.35 re S
q 0.000 g BT 167.24 505.82 Td (25,325,754) Tj ET Q
289.13 515.91 124.72 -28.35 re S
q 0.000 g BT 291.97 505.82 Td (921,961,740) Tj ET Q
413.86 515.91 124.72 -28.35 re S
q 0.000 g BT 416.69 505.82 Td (947,287,494) Tj ET Q
28.35 487.56 136.06 -14.17 re S
q 0.000 g BT 31.18 477.47 Td (Unspecified renal failure) Tj ET Q
164.41 487.56 124.72 -14.17 re S
q 0.000 g BT 167.24 477.47 Td (23,369,142) Tj ET Q
289.13 487.56 124.72 -14.17 re S
q 0.000 g BT 291.97 477.47 Td (18,488,445) Tj ET Q
413.86 487.56 124.72 -14.17 re S
q 0.000 g BT 416.69 477.47 Td (41,857,587) Tj ET Q
28.35 473.39 136.06 -14.17 re S
q 0.000 g BT 31.18 463.30 Td (Urolithiasis) Tj ET Q
164.41 473.39 124.72 -14.17 re S
q 0.000 g BT 167.24 463.30 Td (217,542,683) Tj ET Q
289.13 473.39 124.72 -14.17 re S
q 0.000 g BT 291.97 463.30 Td (153,131,640) Tj ET Q
413.86 473.39 124.72 -14.17 re S
q 0.000 g BT 416.69 463.30 Td (370,674,322) Tj ET Q
BT /F2 10.00 Tf ET
28.35 459.21 136.06 -42.52 re S
q 0.000 g BT 31.18 449.13 Td (Totals for above Diseases) Tj ET Q
q 0.000 g BT 31.18 434.95 Td (of the genitourinary) Tj ET Q
q 0.000 g BT 31.18 420.78 Td (system) Tj ET Q
164.41 459.21 124.72 -42.52 re S
q 0.000 g BT 167.24 449.13 Td (1,669,182,090) Tj ET Q
289.13 459.21 124.72 -42.52 re S
q 0.000 g BT 291.97 449.13 Td (3,082,778,141) Tj ET Q
413.86 459.21 124.72 -42.52 re S
q 0.000 g BT 416.69 449.13 Td (4,751,960,231) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
28.35 402.52 510.24 -14.17 re S
q 0.000 g BT 31.18 392.43 Td (Pregnancy, childbirth and the puerperium) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
BT /F1 10.00 Tf ET
28.35 388.35 136.06 -14.17 re S
q 0.000 g BT 31.18 378.26 Td (Maternal Sepsis) Tj ET Q
164.41 388.35 124.72 -14.17 re S
q 0.000 g BT 167.24 378.26 Td (19,934) Tj ET Q
289.13 388.35 124.72 -14.17 re S
q 0.000 g BT 291.97 378.26 Td (10,433,230) Tj ET Q
413.86 388.35 124.72 -14.17 re S
q 0.000 g BT 416.69 378.26 Td (10,453,164) Tj ET Q
28.35 374.17 136.06 -14.17 re S
q 0.000 g BT 31.18 364.09 Td (Medical abortion) Tj ET Q
164.41 374.17 124.72 -14.17 re S
q 0.000 g BT 167.24 364.09 Td (5,566) Tj ET Q
289.13 374.17 124.72 -14.17 re S
q 0.000 g BT 291.97 364.09 Td (16,190,510) Tj ET Q
413.86 374.17 124.72 -14.17 re S
q 0.000 g BT 416.69 364.09 Td (16,196,076) Tj ET Q
28.35 360.00 136.06 -14.17 re S
q 0.000 g BT 31.18 349.91 Td (Obstructed labour \(Dystocia\)) Tj ET Q
164.41 360.00 124.72 -14.17 re S
q 0.000 g BT 167.24 349.91 Td (108,616) Tj ET Q
289.13 360.00 124.72 -14.17 re S
q 0.000 g BT 291.97 349.91 Td (123,023,647) Tj ET Q
413.86 360.00 124.72 -14.17 re S
q 0.000 g BT 416.69 349.91 Td (123,132,263) Tj ET Q
28.35 345.83 136.06 -56.69 re S
q 0.000 g BT 31.18 335.74 Td (Oedema, proteinuria and) Tj ET Q
q 0.000 g BT 31.18 321.57 Td (hypertensive disorders in) Tj ET Q
q 0.000 g BT 31.18 307.39 Td (pregnancy, childbirth and the) Tj ET Q
q 0.000 g BT 31.18 293.22 Td (puerperium) Tj ET Q
164.41 345.83 124.72 -56.69 re S
q 0.000 g BT 167.24 335.74 Td (30,290) Tj ET Q
289.13 345.83 124.72 -56.69 re S
q 0.000 g BT 291.97 335.74 Td (96,103,510) Tj ET Q
413.86 345.83 124.72 -56.69 re S
q 0.000 g BT 416.69 335.74 Td (96,133,799) Tj ET Q
28.35 289.13 136.06 -42.52 re S
q 0.000 g BT 31.18 279.05 Td (Other complications of) Tj ET Q
q 0.000 g BT 31.18 264.87 Td (pregnancy predominantly) Tj ET Q
q 0.000 g BT 31.18 250.70 Td (during labour and delivery) Tj ET Q
164.41 289.13 124.72 -42.52 re S
q 0.000 g BT 167.24 279.05 Td (486,959) Tj ET Q
289.13 289.13 124.72 -42.52 re S
q 0.000 g BT 291.97 279.05 Td (544,145,082) Tj ET Q
413.86 289.13 124.72 -42.52 re S
q 0.000 g BT 416.69 279.05 Td (544,632,041) Tj ET Q
28.35 246.61 136.06 -42.52 re S
q 0.000 g BT 31.18 236.53 Td (Other complications of) Tj ET Q
q 0.000 g BT 31.18 222.35 Td (pregnancy predominantly in) Tj ET Q
q 0.000 g BT 31.18 208.18 Td (the antenatal period) Tj ET Q
164.41 246.61 124.72 -42.52 re S
q 0.000 g BT 167.24 236.53 Td (1,314,723) Tj ET Q
289.13 246.61 124.72 -42.52 re S
q 0.000 g BT 291.97 236.53 Td (955,366,330) Tj ET Q
413.86 246.61 124.72 -42.52 re S
q 0.000 g BT 416.69 236.53 Td (956,681,053) Tj ET Q
28.35 204.09 136.06 -42.52 re S
q 0.000 g BT 31.18 194.01 Td (Other complications) Tj ET Q
q 0.000 g BT 31.18 179.83 Td (predominantly related to the) Tj ET Q
q 0.000 g BT 31.18 165.66 Td (puerperium) Tj ET Q
164.41 204.09 124.72 -42.52 re S
q 0.000 g BT 167.24 194.01 Td (275,719) Tj ET Q
289.13 204.09 124.72 -42.52 re S
q 0.000 g BT 291.97 194.01 Td (16,381,547) Tj ET Q
413.86 204.09 124.72 -42.52 re S
q 0.000 g BT 416.69 194.01 Td (16,657,265) Tj ET Q
28.35 161.58 136.06 -14.17 re S
q 0.000 g BT 31.18 151.49 Td (Other delivery) Tj ET Q
164.41 161.58 124.72 -14.17 re S
q 0.000 g BT 167.24 151.49 Td (230,955) Tj ET Q
289.13 161.58 124.72 -14.17 re S
q 0.000 g BT 291.97 151.49 Td (8,741,053) Tj ET Q
413.86 161.58 124.72 -14.17 re S
q 0.000 g BT 416.69 151.49 Td (8,972,008) Tj ET Q
28.35 147.40 136.06 -14.17 re S
q 0.000 g BT 31.18 137.32 Td (Other obstetric conditions) Tj ET Q
164.41 147.40 124.72 -14.17 re S
q 0.000 g BT 167.24 137.32 Td (525,538) Tj ET Q
289.13 147.40 124.72 -14.17 re S
q 0.000 g BT 291.97 137.32 Td (290,374,690) Tj ET Q
413.86 147.40 124.72 -14.17 re S
q 0.000 g BT 416.69 137.32 Td (290,900,229) Tj ET Q
28.35 133.23 136.06 -28.35 re S
q 0.000 g BT 31.18 123.14 Td (Other pregnancy with) Tj ET Q
q 0.000 g BT 31.18 108.97 Td (abortive outcome) Tj ET Q
164.41 133.23 124.72 -28.35 re S
q 0.000 g BT 167.24 123.14 Td (260,603) Tj ET Q
289.13 133.23 124.72 -28.35 re S
q 0.000 g BT 291.97 123.14 Td (162,909,760) Tj ET Q
413.86 133.23 124.72 -28.35 re S
q 0.000 g BT 416.69 123.14 Td (163,170,363) Tj ET Q
28.35 104.88 136.06 -14.17 re S
q 0.000 g BT 31.18 94.80 Td (Single spontaneous delivery) Tj ET Q
164.41 104.88 124.72 -14.17 re S
q 0.000 g BT 167.24 94.80 Td (211,137) Tj ET Q
289.13 104.88 124.72 -14.17 re S
q 0.000 g BT 291.97 94.80 Td (242,374,261) Tj ET Q
413.86 104.88 124.72 -14.17 re S
q 0.000 g BT 416.69 94.80 Td (242,585,398) Tj ET Q
BT /F2 10.00 Tf ET
endstream
endobj
15 0 obj
<>
endobj
16 0 obj
<>
stream
2 J
0.85 w
BT /F2 10.00 Tf ET
0.800 0.800 0.800 RG
28.35 813.54 136.06 -42.52 re S
q 0.000 g BT 31.18 803.46 Td (Totals for above) Tj ET Q
q 0.000 g BT 31.18 789.28 Td (Pregnancy, childbirth and) Tj ET Q
q 0.000 g BT 31.18 775.11 Td (the puerperium) Tj ET Q
164.41 813.54 124.72 -42.52 re S
q 0.000 g BT 167.24 803.46 Td (3,470,039) Tj ET Q
289.13 813.54 124.72 -42.52 re S
q 0.000 g BT 291.97 803.46 Td (2,466,043,620) Tj ET Q
413.86 813.54 124.72 -42.52 re S
q 0.000 g BT 416.69 803.46 Td (2,469,513,659) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
28.35 756.85 510.24 -14.17 re S
q 0.000 g BT 31.18 746.76 Td (Certain conditions originating in the perinatal period) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
BT /F1 10.00 Tf ET
28.35 742.68 136.06 -28.35 re S
q 0.000 g BT 31.18 732.59 Td (Birth asphyxia and birth) Tj ET Q
q 0.000 g BT 31.18 718.42 Td (trauma) Tj ET Q
164.41 742.68 124.72 -28.35 re S
q 0.000 g BT 167.24 732.59 Td (120,727,708) Tj ET Q
289.13 742.68 124.72 -28.35 re S
q 0.000 g BT 291.97 732.59 Td (80,373,952) Tj ET Q
413.86 742.68 124.72 -28.35 re S
q 0.000 g BT 416.69 732.59 Td (201,101,660) Tj ET Q
28.35 714.33 136.06 -42.52 re S
q 0.000 g BT 31.18 704.24 Td (Disorders related to short) Tj ET Q
q 0.000 g BT 31.18 690.07 Td (gestation and low birth) Tj ET Q
q 0.000 g BT 31.18 675.90 Td (weight) Tj ET Q
164.41 714.33 124.72 -42.52 re S
q 0.000 g BT 167.24 704.24 Td (330,761,536) Tj ET Q
289.13 714.33 124.72 -42.52 re S
q 0.000 g BT 291.97 704.24 Td (280,714,224) Tj ET Q
413.86 714.33 124.72 -42.52 re S
q 0.000 g BT 416.69 704.24 Td (611,475,760) Tj ET Q
28.35 671.81 136.06 -28.35 re S
q 0.000 g BT 31.18 661.72 Td (Other conditions originating) Tj ET Q
q 0.000 g BT 31.18 647.55 Td (in the perinatal period) Tj ET Q
164.41 671.81 124.72 -28.35 re S
q 0.000 g BT 167.24 661.72 Td (133,712,960) Tj ET Q
289.13 671.81 124.72 -28.35 re S
q 0.000 g BT 291.97 661.72 Td (113,172,673) Tj ET Q
413.86 671.81 124.72 -28.35 re S
q 0.000 g BT 416.69 661.72 Td (246,885,634) Tj ET Q
28.35 643.46 136.06 -28.35 re S
q 0.000 g BT 31.18 633.38 Td (Slow fetal growth and fetal) Tj ET Q
q 0.000 g BT 31.18 619.20 Td (malnutrition) Tj ET Q
164.41 643.46 124.72 -28.35 re S
q 0.000 g BT 167.24 633.38 Td (5,931,065) Tj ET Q
289.13 643.46 124.72 -28.35 re S
q 0.000 g BT 291.97 633.38 Td (6,387,215) Tj ET Q
413.86 643.46 124.72 -28.35 re S
q 0.000 g BT 416.69 633.38 Td (12,318,281) Tj ET Q
BT /F2 10.00 Tf ET
28.35 615.12 136.06 -42.52 re S
q 0.000 g BT 31.18 605.03 Td (Totals for above Certain) Tj ET Q
q 0.000 g BT 31.18 590.86 Td (conditions originating in) Tj ET Q
q 0.000 g BT 31.18 576.69 Td (the perinatal period) Tj ET Q
164.41 615.12 124.72 -42.52 re S
q 0.000 g BT 167.24 605.03 Td (591,133,270) Tj ET Q
289.13 615.12 124.72 -42.52 re S
q 0.000 g BT 291.97 605.03 Td (480,648,064) Tj ET Q
413.86 615.12 124.72 -42.52 re S
q 0.000 g BT 416.69 605.03 Td (1,071,781,335) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
28.35 558.43 510.24 -14.17 re S
q 0.000 g BT 31.18 548.34 Td (Congenital malformations, deformations and chromosomal abnormalities) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
BT /F1 10.00 Tf ET
28.35 544.25 136.06 -14.17 re S
q 0.000 g BT 31.18 534.17 Td (Congenital heart anomalies) Tj ET Q
164.41 544.25 124.72 -14.17 re S
q 0.000 g BT 167.24 534.17 Td (169,385,976) Tj ET Q
289.13 544.25 124.72 -14.17 re S
q 0.000 g BT 291.97 534.17 Td (148,937,286) Tj ET Q
413.86 544.25 124.72 -14.17 re S
q 0.000 g BT 416.69 534.17 Td (318,323,262) Tj ET Q
28.35 530.08 136.06 -56.69 re S
q 0.000 g BT 31.18 519.99 Td (Other congenital) Tj ET Q
q 0.000 g BT 31.18 505.82 Td (malformations, deformations) Tj ET Q
q 0.000 g BT 31.18 491.65 Td (and chromosomal) Tj ET Q
q 0.000 g BT 31.18 477.47 Td (abnormalities) Tj ET Q
164.41 530.08 124.72 -56.69 re S
q 0.000 g BT 167.24 519.99 Td (264,797,217) Tj ET Q
289.13 530.08 124.72 -56.69 re S
q 0.000 g BT 291.97 519.99 Td (195,093,639) Tj ET Q
413.86 530.08 124.72 -56.69 re S
q 0.000 g BT 416.69 519.99 Td (459,890,856) Tj ET Q
BT /F2 10.00 Tf ET
28.35 473.39 136.06 -70.87 re S
q 0.000 g BT 31.18 463.30 Td (Totals for above) Tj ET Q
q 0.000 g BT 31.18 449.13 Td (Congenital malformations,) Tj ET Q
q 0.000 g BT 31.18 434.95 Td (deformations and) Tj ET Q
q 0.000 g BT 31.18 420.78 Td (chromosomal) Tj ET Q
q 0.000 g BT 31.18 406.61 Td (abnormalities) Tj ET Q
164.41 473.39 124.72 -70.87 re S
q 0.000 g BT 167.24 463.30 Td (434,183,193) Tj ET Q
289.13 473.39 124.72 -70.87 re S
q 0.000 g BT 291.97 463.30 Td (344,030,925) Tj ET Q
413.86 473.39 124.72 -70.87 re S
q 0.000 g BT 416.69 463.30 Td (778,214,118) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
28.35 388.35 510.24 -14.17 re S
q 0.000 g BT 31.18 378.26 Td (Symptoms, signs & abnormal clinical & laboratory findings, not elsewhere classified) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
BT /F1 10.00 Tf ET
28.35 374.17 136.06 -14.17 re S
q 0.000 g BT 31.18 364.09 Td (Abdominal and pelvic pain) Tj ET Q
164.41 374.17 124.72 -14.17 re S
q 0.000 g BT 167.24 364.09 Td (227,583,288) Tj ET Q
289.13 374.17 124.72 -14.17 re S
q 0.000 g BT 291.97 364.09 Td (452,601,251) Tj ET Q
413.86 374.17 124.72 -14.17 re S
q 0.000 g BT 416.69 364.09 Td (680,184,540) Tj ET Q
28.35 360.00 136.06 -42.52 re S
q 0.000 g BT 31.18 349.91 Td (Other symptoms, signs and) Tj ET Q
q 0.000 g BT 31.18 335.74 Td (abnormal clinical and) Tj ET Q
q 0.000 g BT 31.18 321.57 Td (laboratory findings) Tj ET Q
164.41 360.00 124.72 -42.52 re S
q 0.000 g BT 167.24 349.91 Td (2,352,418,413) Tj ET Q
289.13 360.00 124.72 -42.52 re S
q 0.000 g BT 291.97 349.91 Td (2,715,970,540) Tj ET Q
413.86 360.00 124.72 -42.52 re S
q 0.000 g BT 416.69 349.91 Td (5,068,388,953) Tj ET Q
28.35 317.48 136.06 -14.17 re S
q 0.000 g BT 31.18 307.39 Td (Pain in throat and chest) Tj ET Q
164.41 317.48 124.72 -14.17 re S
q 0.000 g BT 167.24 307.39 Td (249,446,948) Tj ET Q
289.13 317.48 124.72 -14.17 re S
q 0.000 g BT 291.97 307.39 Td (251,262,437) Tj ET Q
413.86 317.48 124.72 -14.17 re S
q 0.000 g BT 416.69 307.39 Td (500,709,385) Tj ET Q
28.35 303.31 136.06 -42.52 re S
q 0.000 g BT 31.18 293.22 Td (Unknown and unspecified) Tj ET Q
q 0.000 g BT 31.18 279.05 Td (causes of morbidity \(incl.) Tj ET Q
q 0.000 g BT 31.18 264.87 Td (those without a diagnosis\)) Tj ET Q
164.41 303.31 124.72 -42.52 re S
q 0.000 g BT 167.24 293.22 Td (317,466,281) Tj ET Q
289.13 303.31 124.72 -42.52 re S
q 0.000 g BT 291.97 293.22 Td (460,918,072) Tj ET Q
413.86 303.31 124.72 -42.52 re S
q 0.000 g BT 416.69 293.22 Td (778,384,353) Tj ET Q
BT /F2 10.00 Tf ET
28.35 260.79 136.06 -70.87 re S
q 0.000 g BT 31.18 250.70 Td (Totals for above) Tj ET Q
q 0.000 g BT 31.18 236.53 Td (Symptoms, signs &) Tj ET Q
q 0.000 g BT 31.18 222.35 Td (abnormal clinical &) Tj ET Q
q 0.000 g BT 31.18 208.18 Td (laboratory findings, not) Tj ET Q
q 0.000 g BT 31.18 194.01 Td (elsewhere classified) Tj ET Q
164.41 260.79 124.72 -70.87 re S
q 0.000 g BT 167.24 250.70 Td (3,146,914,930) Tj ET Q
289.13 260.79 124.72 -70.87 re S
q 0.000 g BT 291.97 250.70 Td (3,880,752,300) Tj ET Q
413.86 260.79 124.72 -70.87 re S
q 0.000 g BT 416.69 250.70 Td (7,027,667,230) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
28.35 175.75 510.24 -14.17 re S
q 0.000 g BT 31.18 165.66 Td (Injury, poisoning & certain other consequences of external causes \(injury coding type 1\)) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
BT /F1 10.00 Tf ET
28.35 161.58 136.06 -14.17 re S
q 0.000 g BT 31.18 151.49 Td (Burns and corrosions) Tj ET Q
164.41 161.58 124.72 -14.17 re S
q 0.000 g BT 167.24 151.49 Td (61,284,676) Tj ET Q
289.13 161.58 124.72 -14.17 re S
q 0.000 g BT 291.97 151.49 Td (23,674,480) Tj ET Q
413.86 161.58 124.72 -14.17 re S
q 0.000 g BT 416.69 151.49 Td (84,959,156) Tj ET Q
28.35 147.40 136.06 -42.52 re S
q 0.000 g BT 31.18 137.32 Td (Complications of surgical) Tj ET Q
q 0.000 g BT 31.18 123.14 Td (and medical care, not) Tj ET Q
q 0.000 g BT 31.18 108.97 Td (elsewhere classified) Tj ET Q
164.41 147.40 124.72 -42.52 re S
q 0.000 g BT 167.24 137.32 Td (499,439,121) Tj ET Q
289.13 147.40 124.72 -42.52 re S
q 0.000 g BT 291.97 137.32 Td (465,301,941) Tj ET Q
413.86 147.40 124.72 -42.52 re S
q 0.000 g BT 416.69 137.32 Td (964,741,062) Tj ET Q
28.35 104.88 136.06 -14.17 re S
q 0.000 g BT 31.18 94.80 Td (Fracture of femur) Tj ET Q
164.41 104.88 124.72 -14.17 re S
q 0.000 g BT 167.24 94.80 Td (537,681,971) Tj ET Q
289.13 104.88 124.72 -14.17 re S
q 0.000 g BT 291.97 94.80 Td (875,118,009) Tj ET Q
413.86 104.88 124.72 -14.17 re S
q 0.000 g BT 416.69 94.80 Td (1,412,799,981) Tj ET Q
28.35 90.71 136.06 -14.17 re S
q 0.000 g BT 31.18 80.62 Td (Fracture of forearm) Tj ET Q
164.41 90.71 124.72 -14.17 re S
q 0.000 g BT 167.24 80.62 Td (92,150,103) Tj ET Q
289.13 90.71 124.72 -14.17 re S
q 0.000 g BT 291.97 80.62 Td (108,361,174) Tj ET Q
413.86 90.71 124.72 -14.17 re S
q 0.000 g BT 416.69 80.62 Td (200,511,276) Tj ET Q
endstream
endobj
17 0 obj
<>
endobj
18 0 obj
<>
stream
2 J
0.85 w
BT /F1 10.00 Tf ET
0.800 0.800 0.800 RG
28.35 813.54 136.06 -28.35 re S
q 0.000 g BT 31.18 803.46 Td (Fracture of lower leg,) Tj ET Q
q 0.000 g BT 31.18 789.28 Td (including ankle) Tj ET Q
164.41 813.54 124.72 -28.35 re S
q 0.000 g BT 167.24 803.46 Td (3,692,550,812) Tj ET Q
289.13 813.54 124.72 -28.35 re S
q 0.000 g BT 291.97 803.46 Td (5,396,558,049) Tj ET Q
413.86 813.54 124.72 -28.35 re S
q 0.000 g BT 416.69 803.46 Td (9,089,108,861) Tj ET Q
28.35 785.20 136.06 -14.17 re S
q 0.000 g BT 31.18 775.11 Td (Intracranial injury) Tj ET Q
164.41 785.20 124.72 -14.17 re S
q 0.000 g BT 167.24 775.11 Td (217,289,570) Tj ET Q
289.13 785.20 124.72 -14.17 re S
q 0.000 g BT 291.97 775.11 Td (101,293,284) Tj ET Q
413.86 785.20 124.72 -14.17 re S
q 0.000 g BT 416.69 775.11 Td (318,582,854) Tj ET Q
28.35 771.02 136.06 -28.35 re S
q 0.000 g BT 31.18 760.94 Td (Other and unspecified effects) Tj ET Q
q 0.000 g BT 31.18 746.76 Td (of external causes) Tj ET Q
164.41 771.02 124.72 -28.35 re S
q 0.000 g BT 167.24 760.94 Td (49,962,100) Tj ET Q
289.13 771.02 124.72 -28.35 re S
q 0.000 g BT 291.97 760.94 Td (33,202,946) Tj ET Q
413.86 771.02 124.72 -28.35 re S
q 0.000 g BT 416.69 760.94 Td (83,165,046) Tj ET Q
28.35 742.68 136.06 -14.17 re S
q 0.000 g BT 31.18 732.59 Td (Other injuries) Tj ET Q
164.41 742.68 124.72 -14.17 re S
q 0.000 g BT 167.24 732.59 Td (783,314,451) Tj ET Q
289.13 742.68 124.72 -14.17 re S
q 0.000 g BT 291.97 732.59 Td (538,734,145) Tj ET Q
413.86 742.68 124.72 -14.17 re S
q 0.000 g BT 416.69 732.59 Td (1,322,048,596) Tj ET Q
28.35 728.50 136.06 -14.17 re S
q 0.000 g BT 31.18 718.42 Td (Other injuries to the head) Tj ET Q
164.41 728.50 124.72 -14.17 re S
q 0.000 g BT 167.24 718.42 Td (195,446,237) Tj ET Q
289.13 728.50 124.72 -14.17 re S
q 0.000 g BT 291.97 718.42 Td (80,744,136) Tj ET Q
413.86 728.50 124.72 -14.17 re S
q 0.000 g BT 416.69 718.42 Td (276,190,373) Tj ET Q
28.35 714.33 136.06 -56.69 re S
q 0.000 g BT 31.18 704.24 Td (Poisonings by drugs,) Tj ET Q
q 0.000 g BT 31.18 690.07 Td (medicaments & biological) Tj ET Q
q 0.000 g BT 31.18 675.90 Td (substances & toxic effects of) Tj ET Q
q 0.000 g BT 31.18 661.72 Td (substances chiefly ...) Tj ET Q
164.41 714.33 124.72 -56.69 re S
q 0.000 g BT 167.24 704.24 Td (61,241,108) Tj ET Q
289.13 714.33 124.72 -56.69 re S
q 0.000 g BT 291.97 704.24 Td (71,292,273) Tj ET Q
413.86 714.33 124.72 -56.69 re S
q 0.000 g BT 416.69 704.24 Td (132,533,381) Tj ET Q
28.35 657.64 136.06 -56.69 re S
q 0.000 g BT 31.18 647.55 Td (Sequelae of injuries, of) Tj ET Q
q 0.000 g BT 31.18 633.38 Td (poisoning and of other) Tj ET Q
q 0.000 g BT 31.18 619.20 Td (consequences of external) Tj ET Q
q 0.000 g BT 31.18 605.03 Td (causes) Tj ET Q
164.41 657.64 124.72 -56.69 re S
q 0.000 g BT 167.24 647.55 Td (0) Tj ET Q
289.13 657.64 124.72 -56.69 re S
q 0.000 g BT 291.97 647.55 Td (0) Tj ET Q
413.86 657.64 124.72 -56.69 re S
q 0.000 g BT 416.69 647.55 Td (0) Tj ET Q
BT /F2 10.00 Tf ET
28.35 600.95 136.06 -70.87 re S
q 0.000 g BT 31.18 590.86 Td (Totals for above Injury,) Tj ET Q
q 0.000 g BT 31.18 576.69 Td (poisoning & certain other) Tj ET Q
q 0.000 g BT 31.18 562.51 Td (consequences of external) Tj ET Q
q 0.000 g BT 31.18 548.34 Td (causes \(injury coding type) Tj ET Q
q 0.000 g BT 31.18 534.17 Td (1\)) Tj ET Q
164.41 600.95 124.72 -70.87 re S
q 0.000 g BT 167.24 590.86 Td (6,190,360,148) Tj ET Q
289.13 600.95 124.72 -70.87 re S
q 0.000 g BT 291.97 590.86 Td (7,694,280,439) Tj ET Q
413.86 600.95 124.72 -70.87 re S
q 0.000 g BT 416.69 590.86 Td (13,884,640,586) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
28.35 515.91 510.24 -14.17 re S
q 0.000 g BT 31.18 505.82 Td (External causes of morbidity and mortality \(injury coding type 2\)) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
BT /F1 10.00 Tf ET
28.35 501.73 136.06 -14.17 re S
q 0.000 g BT 31.18 491.65 Td (Drowning) Tj ET Q
164.41 501.73 124.72 -14.17 re S
q 0.000 g BT 167.24 491.65 Td (2,088,059) Tj ET Q
289.13 501.73 124.72 -14.17 re S
q 0.000 g BT 291.97 491.65 Td (308,410) Tj ET Q
413.86 501.73 124.72 -14.17 re S
q 0.000 g BT 416.69 491.65 Td (2,396,469) Tj ET Q
28.35 487.56 136.06 -14.17 re S
q 0.000 g BT 31.18 477.47 Td (Falls) Tj ET Q
164.41 487.56 124.72 -14.17 re S
q 0.000 g BT 167.24 477.47 Td (5,249,869) Tj ET Q
289.13 487.56 124.72 -14.17 re S
q 0.000 g BT 291.97 477.47 Td (739,078) Tj ET Q
413.86 487.56 124.72 -14.17 re S
q 0.000 g BT 416.69 477.47 Td (5,988,948) Tj ET Q
28.35 473.39 136.06 -14.17 re S
q 0.000 g BT 31.18 463.30 Td (Fires) Tj ET Q
164.41 473.39 124.72 -14.17 re S
q 0.000 g BT 167.24 463.30 Td (1,331,805) Tj ET Q
289.13 473.39 124.72 -14.17 re S
q 0.000 g BT 291.97 463.30 Td (390,840) Tj ET Q
413.86 473.39 124.72 -14.17 re S
q 0.000 g BT 416.69 463.30 Td (1,722,645) Tj ET Q
28.35 459.21 136.06 -28.35 re S
q 0.000 g BT 31.18 449.13 Td (Injuries of undetermined) Tj ET Q
q 0.000 g BT 31.18 434.95 Td (intent) Tj ET Q
164.41 459.21 124.72 -28.35 re S
q 0.000 g BT 167.24 449.13 Td (7,065,086) Tj ET Q
289.13 459.21 124.72 -28.35 re S
q 0.000 g BT 291.97 449.13 Td (2,742,812) Tj ET Q
413.86 459.21 124.72 -28.35 re S
q 0.000 g BT 416.69 449.13 Td (9,807,898) Tj ET Q
28.35 430.87 136.06 -14.17 re S
q 0.000 g BT 31.18 420.78 Td (Other intentional injuries) Tj ET Q
164.41 430.87 124.72 -14.17 re S
q 0.000 g BT 167.24 420.78 Td (239,605) Tj ET Q
289.13 430.87 124.72 -14.17 re S
q 0.000 g BT 291.97 420.78 Td (13,462) Tj ET Q
413.86 430.87 124.72 -14.17 re S
q 0.000 g BT 416.69 420.78 Td (253,067) Tj ET Q
28.35 416.69 136.06 -14.17 re S
q 0.000 g BT 31.18 406.61 Td (Other unintentional injuries) Tj ET Q
164.41 416.69 124.72 -14.17 re S
q 0.000 g BT 167.24 406.61 Td (10,830,238) Tj ET Q
289.13 416.69 124.72 -14.17 re S
q 0.000 g BT 291.97 406.61 Td (1,290,848) Tj ET Q
413.86 416.69 124.72 -14.17 re S
q 0.000 g BT 416.69 406.61 Td (12,121,086) Tj ET Q
28.35 402.52 136.06 -14.17 re S
q 0.000 g BT 31.18 392.43 Td (Poisonings) Tj ET Q
164.41 402.52 124.72 -14.17 re S
q 0.000 g BT 167.24 392.43 Td (16,501,988) Tj ET Q
289.13 402.52 124.72 -14.17 re S
q 0.000 g BT 291.97 392.43 Td (4,609,116) Tj ET Q
413.86 402.52 124.72 -14.17 re S
q 0.000 g BT 416.69 392.43 Td (21,111,105) Tj ET Q
28.35 388.35 136.06 -14.17 re S
q 0.000 g BT 31.18 378.26 Td (Road traffic accidents) Tj ET Q
164.41 388.35 124.72 -14.17 re S
q 0.000 g BT 167.24 378.26 Td (17,470,516) Tj ET Q
289.13 388.35 124.72 -14.17 re S
q 0.000 g BT 291.97 378.26 Td (4,033,499) Tj ET Q
413.86 388.35 124.72 -14.17 re S
q 0.000 g BT 416.69 378.26 Td (21,504,015) Tj ET Q
28.35 374.17 136.06 -14.17 re S
q 0.000 g BT 31.18 364.09 Td (Self-inflicted injuries) Tj ET Q
164.41 374.17 124.72 -14.17 re S
q 0.000 g BT 167.24 364.09 Td (40,594,756) Tj ET Q
289.13 374.17 124.72 -14.17 re S
q 0.000 g BT 291.97 364.09 Td (8,408,532) Tj ET Q
413.86 374.17 124.72 -14.17 re S
q 0.000 g BT 416.69 364.09 Td (49,003,288) Tj ET Q
28.35 360.00 136.06 -14.17 re S
q 0.000 g BT 31.18 349.91 Td (Violence) Tj ET Q
164.41 360.00 124.72 -14.17 re S
q 0.000 g BT 167.24 349.91 Td (4,699,294) Tj ET Q
289.13 360.00 124.72 -14.17 re S
q 0.000 g BT 291.97 349.91 Td (1,018,599) Tj ET Q
413.86 360.00 124.72 -14.17 re S
q 0.000 g BT 416.69 349.91 Td (5,717,893) Tj ET Q
BT /F2 10.00 Tf ET
28.35 345.83 136.06 -56.69 re S
q 0.000 g BT 31.18 335.74 Td (Totals for above External) Tj ET Q
q 0.000 g BT 31.18 321.57 Td (causes of morbidity and) Tj ET Q
q 0.000 g BT 31.18 307.39 Td (mortality \(injury coding) Tj ET Q
q 0.000 g BT 31.18 293.22 Td (type 2\)) Tj ET Q
164.41 345.83 124.72 -56.69 re S
q 0.000 g BT 167.24 335.74 Td (106,071,217) Tj ET Q
289.13 345.83 124.72 -56.69 re S
q 0.000 g BT 291.97 335.74 Td (23,555,196) Tj ET Q
413.86 345.83 124.72 -56.69 re S
q 0.000 g BT 416.69 335.74 Td (129,626,413) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
28.35 274.96 510.24 -14.17 re S
q 0.000 g BT 31.18 264.87 Td (Factors influencing health status and contact with health services) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
BT /F1 10.00 Tf ET
28.35 260.79 136.06 -14.17 re S
q 0.000 g BT 31.18 250.70 Td (Contraceptive management) Tj ET Q
164.41 260.79 124.72 -14.17 re S
q 0.000 g BT 167.24 250.70 Td (60,089,206) Tj ET Q
289.13 260.79 124.72 -14.17 re S
q 0.000 g BT 291.97 250.70 Td (94,369,630) Tj ET Q
413.86 260.79 124.72 -14.17 re S
q 0.000 g BT 416.69 250.70 Td (154,458,837) Tj ET Q
28.35 246.61 136.06 -42.52 re S
q 0.000 g BT 31.18 236.53 Td (Live born infants according) Tj ET Q
q 0.000 g BT 31.18 222.35 Td (to place of birth \(healthy) Tj ET Q
q 0.000 g BT 31.18 208.18 Td (newborn babies\)) Tj ET Q
164.41 246.61 124.72 -42.52 re S
q 0.000 g BT 167.24 236.53 Td (142,206,341) Tj ET Q
289.13 246.61 124.72 -42.52 re S
q 0.000 g BT 291.97 236.53 Td (140,609,614) Tj ET Q
413.86 246.61 124.72 -42.52 re S
q 0.000 g BT 416.69 236.53 Td (282,815,955) Tj ET Q
28.35 204.09 136.06 -42.52 re S
q 0.000 g BT 31.18 194.01 Td (Medical observation and) Tj ET Q
q 0.000 g BT 31.18 179.83 Td (evaluation for suspected) Tj ET Q
q 0.000 g BT 31.18 165.66 Td (diseases and conditions) Tj ET Q
164.41 204.09 124.72 -42.52 re S
q 0.000 g BT 167.24 194.01 Td (451,513,801) Tj ET Q
289.13 204.09 124.72 -42.52 re S
q 0.000 g BT 291.97 194.01 Td (1,237,485,552) Tj ET Q
413.86 204.09 124.72 -42.52 re S
q 0.000 g BT 416.69 194.01 Td (1,688,999,353) Tj ET Q
28.35 161.58 136.06 -42.52 re S
q 0.000 g BT 31.18 151.49 Td (Other factors influencing) Tj ET Q
q 0.000 g BT 31.18 137.32 Td (health status and contact) Tj ET Q
q 0.000 g BT 31.18 123.14 Td (with health services) Tj ET Q
164.41 161.58 124.72 -42.52 re S
q 0.000 g BT 167.24 151.49 Td (4,778,739,410) Tj ET Q
289.13 161.58 124.72 -42.52 re S
q 0.000 g BT 291.97 151.49 Td (4,918,506,919) Tj ET Q
413.86 161.58 124.72 -42.52 re S
q 0.000 g BT 416.69 151.49 Td (9,697,246,329) Tj ET Q
28.35 119.06 136.06 -42.52 re S
q 0.000 g BT 31.18 108.97 Td (Other medical care \(including) Tj ET Q
q 0.000 g BT 31.18 94.80 Td (radiotherapy and) Tj ET Q
q 0.000 g BT 31.18 80.62 Td (chemotherapy sessions\)) Tj ET Q
164.41 119.06 124.72 -42.52 re S
q 0.000 g BT 167.24 108.97 Td (1,950,921,686) Tj ET Q
289.13 119.06 124.72 -42.52 re S
q 0.000 g BT 291.97 108.97 Td (2,364,847,842) Tj ET Q
413.86 119.06 124.72 -42.52 re S
q 0.000 g BT 416.69 108.97 Td (4,315,769,528) Tj ET Q
BT /F2 10.00 Tf ET
endstream
endobj
19 0 obj
<>
endobj
20 0 obj
<>
stream
2 J
0.85 w
BT /F2 10.00 Tf ET
0.800 0.800 0.800 RG
28.35 813.54 136.06 -56.69 re S
q 0.000 g BT 31.18 803.46 Td (Totals for above Factors) Tj ET Q
q 0.000 g BT 31.18 789.28 Td (influencing health status) Tj ET Q
q 0.000 g BT 31.18 775.11 Td (and contact with health) Tj ET Q
q 0.000 g BT 31.18 760.94 Td (services) Tj ET Q
164.41 813.54 124.72 -56.69 re S
q 0.000 g BT 167.24 803.46 Td (7,383,470,445) Tj ET Q
289.13 813.54 124.72 -56.69 re S
q 0.000 g BT 291.97 803.46 Td (8,755,819,557) Tj ET Q
413.86 813.54 124.72 -56.69 re S
q 0.000 g BT 416.69 803.46 Td (16,139,290,002) Tj ET Q
0.800 0.800 0.800 RG
0.85 w
28.35 742.68 136.06 -14.17 re S
q 0.000 g BT 31.18 732.59 Td (Totals) Tj ET Q
164.41 742.68 124.72 -14.17 re S
q 0.000 g BT 167.24 732.59 Td (52,687,068,092) Tj ET Q
289.13 742.68 124.72 -14.17 re S
q 0.000 g BT 291.97 732.59 Td (59,709,309,744) Tj ET Q
413.86 742.68 124.72 -14.17 re S
q 0.000 g BT 416.69 732.59 Td (112,396,377,836) Tj ET Q
0.800 0.800 0.800 RG
0.00 w
BT /F2 12.00 Tf ET
28.35 714.33 510.24 -14.17 re S
q 0.000 g BT 31.18 703.64 Td (Notes:) Tj ET Q
0.800 0.800 0.800 RG
0.00 w
BT /F1 10.00 Tf ET
BT /F1 9.00 Tf ET
28.35 700.16 28.35 -28.35 re S
q 0.000 g BT 31.18 690.37 Td (1.) Tj ET Q
56.69 700.16 481.89 -28.35 re S
q 0.000 g BT 59.53 690.37 Td (Please read the appropriate Economic Burden of Illness in Canada 2010 Report in order to understand the) Tj ET Q
q 0.000 g BT 59.53 676.20 Td ( limitations of the data.) Tj ET Q
28.35 671.81 28.35 -42.52 re S
q 0.000 g BT 31.18 662.02 Td (2.) Tj ET Q
56.69 671.81 481.89 -42.52 re S
q 0.000 g BT 59.53 662.02 Td (Data are grouped by ICD-10 Chapter and diagnostic categories which are based on the International Short) Tj ET Q
q 0.000 g BT 59.53 647.85 Td ( List of Hospital Morbidity Tabulation \(ISHMT\). Please see the EBIC 2010 Report for the diagnostic categories) Tj ET Q
q 0.000 g BT 59.53 633.68 Td (and associated ICD-10 codes.) Tj ET Q
28.35 629.29 28.35 -56.69 re S
q 0.000 g BT 31.18 619.50 Td (3.) Tj ET Q
56.69 629.29 481.89 -56.69 re S
q 0.000 g BT 59.53 619.50 Td (ICD Chapter XIX, Injury, poisoning and certain other consequences of external causes \(Injury coding type 1\)) Tj ET Q
q 0.000 g BT 59.53 605.33 Td ( and Chapter XX, External causes of morbidity and mortality \(Injury coding type 2\) have been combined. Note) Tj ET Q
q 0.000 g BT 59.53 591.16 Td (that Mortality data was originally classified) Tj ET Q
q 0.000 g BT 59.53 576.99 Td ( according to Chapter XX only, while the other data were classified by Chapter XIX.) Tj ET Q
28.35 572.60 28.35 -14.17 re S
q 0.000 g BT 31.18 562.81 Td (4.) Tj ET Q
56.69 572.60 481.89 -14.17 re S
q 0.000 g BT 59.53 562.81 Td (Drug costs for the territories are not available.) Tj ET Q
endstream
endobj
1 0 obj
<>
endobj
21 0 obj
<>
endobj
22 0 obj
<>
endobj
2 0 obj
<<
/ProcSet [/PDF /Text /ImageB /ImageC /ImageI]
/Font <<
/F1 21 0 R
/F2 22 0 R
>>
/XObject <<
>>
>>
endobj
23 0 obj
<<
/Producer (FPDF 1.6)
/Title (Economic Burden of Illness in Canada)
/Author (Public Health Agency of Canada)
/Keywords (2010 - Canada - All Ages - All Costs)
/CreationDate (D:20240329035145)
>>
endobj
24 0 obj
<<
/Type /Catalog
/Pages 1 0 R
/OpenAction [3 0 R /FitH null]
/PageLayout /OneColumn
>>
endobj
xref
0 25
0000000000 65535 f
0000090531 00000 n
0000090870 00000 n
0000000009 00000 n
0000000087 00000 n
0000011770 00000 n
0000011848 00000 n
0000022034 00000 n
0000022112 00000 n
0000033985 00000 n
0000034064 00000 n
0000046069 00000 n
0000046149 00000 n
0000057804 00000 n
0000057884 00000 n
0000068329 00000 n
0000068409 00000 n
0000077259 00000 n
0000077339 00000 n
0000087625 00000 n
0000087705 00000 n
0000090671 00000 n
0000090768 00000 n
0000090986 00000 n
0000091198 00000 n
trailer
<<
/Size 25
/Root 24 0 R
/Info 23 0 R
>>
startxref
91302
%%EOF
Economic Burden of Illness in Canada custom report
Other symptoms, signs and abnormal clinical and laboratory findings
2,352,418,413
2,715,970,540
9,033,105
Pain in throat and chest
249,446,948
251,262,437
47,100,005
Unknown and unspecified causes of morbidity (incl. those without a diagnosis)
317,466,281
460,918,072
279,748
Totals for above Symptoms, signs & abnormal clinical & laboratory findings, not elsewhere classified
3,146,914,930
3,880,752,300
7,027,667,230
Injury, poisoning & certain other consequences of external causes (injury coding type 1)
Burns and corrosions
61,284,676
23,674,480
7,421,608
Complications of surgical and medical care, not elsewhere classified
499,439,121
465,301,941
41,492,509
Fracture of femur
537,681,971
875,118,009
783,774,563
Fracture of forearm
92,150,103
108,361,174
46,691,018
Fracture of lower leg, including ankle
3,692,550,812
5,396,558,049
8,506,353,423
Intracranial injury
217,289,570
101,293,284
37,039,185
Other and unspecified effects of external causes
49,962,100
33,202,946
34,061,347
Other injuries
783,314,451
538,734,145
445,270,552
Other injuries to the head
195,446,237
80,744,136
38,652,924
Poisonings by drugs, medicaments & biological substances & toxic effects of substances chiefly ...
61,241,108
71,292,273
37,321,395
Sequelae of injuries, of poisoning and of other consequences of external causes
0
0
0
Totals for above Injury, poisoning & certain other consequences of external causes (injury coding type 1)
6,190,360,148
7,694,280,439
13,884,640,586
External causes of morbidity and mortality (injury coding type 2)
Drowning
2,088,059
308,410
2,396,469
Falls
5,249,869
739,078
5,959,422
Fires
1,331,805
390,840
1,722,645
Injuries of undetermined intent
7,065,086
2,742,812
9,807,898
Other intentional injuries
239,605
13,462
253,067
Other unintentional injuries
10,830,238
1,290,848
12,093,679
Poisonings
16,501,988
4,609,116
21,108,591
Road traffic accidents
17,470,516
4,033,499
21,504,015
Self-inflicted injuries
40,594,756
8,408,532
49,003,288
Violence
4,699,294
1,018,599
5,717,893
Totals for above External causes of morbidity and mortality (injury coding type 2)
106,071,217
23,555,196
129,626,413
Factors influencing health status and contact with health services
Contraceptive management
60,089,206
94,369,630
2,408,698
Live born infants according to place of birth (healthy newborn babies)
142,206,341
140,609,614
26,665
Medical observation and evaluation for suspected diseases and conditions
451,513,801
1,237,485,552
600,853,923
Other factors influencing health status and contact with health services
4,778,739,410
4,918,506,919
146,097,159
Other medical care (including radiotherapy and chemotherapy sessions)
1,950,921,686
2,364,847,842
62,273,285
Totals for above Factors influencing health status and contact with health services
7,383,470,445
8,755,819,557
16,139,290,002
Totals
52,687,068,092
59,709,309,744
112,396,377,836
Notes:
Please read the appropriate Economic Burden of Illness in Canada 2010 Report in order to understand the
limitations of the data.
Data are grouped by ICD-10 Chapter and diagnostic categories which are based on the International Short
List of Hospital Morbidity Tabulation (ISHMT). Please see the EBIC 2010 Report for the diagnostic categories and associated ICD-10 codes.
ICD Chapter XIX, Injury, poisoning and certain other consequences of external causes (Injury coding type 1)
and Chapter XX, External causes of morbidity and mortality (Injury coding type 2) have been combined. Note that Mortality data was originally classified
according to Chapter XX only, while the other data were classified by Chapter XIX.